这是一篇来自已证抗体库的有关人类 CD3E的综述,是根据861篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD3E 抗体。
CD3E 同义词: IMD18; T3E; TCRE

BioLegend
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, HIT3A)被用于被用于流式细胞仪在人类样本上. Sci Adv (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Front Immunol (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠; 1:100; 图 1e
BioLegend CD3E抗体(Biolegend, 300459)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 1e). Front Immunol (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 小鼠; 图 s1a
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在小鼠样本上 (图 s1a). J Immunother Cancer (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 5:100; 图 4a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上浓度为5:100 (图 4a). Nat Commun (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 6c, 6f
BioLegend CD3E抗体(BioLegend, 300430)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 6c, 6f). Nat Commun (2021) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 1 ug/ul; 图 4h
BioLegend CD3E抗体(BioLegend, 300314)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ul (图 4h). J Immunother Cancer (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:50; 图 s4
BioLegend CD3E抗体(BioLegend, 300406)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s4). Nat Med (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5e
BioLegend CD3E抗体(Biolegend, 344816)被用于被用于流式细胞仪在人类样本上 (图 5e). Cell (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 5e
BioLegend CD3E抗体(Biolegend, 317302)被用于被用于流式细胞仪在人类样本上 (图 5e). Cell (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5e
BioLegend CD3E抗体(Biolegend, 344816)被用于被用于流式细胞仪在人类样本上 (图 5e). elife (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5e
BioLegend CD3E抗体(Biolegend, 344816)被用于被用于流式细胞仪在人类样本上 (图 5e). Front Cell Infect Microbiol (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5e
BioLegend CD3E抗体(Biolegend, 344816)被用于被用于流式细胞仪在人类样本上 (图 5e). Nature (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Front Immunol (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2b
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 2b). Cancers (Basel) (2021) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:400
BioLegend CD3E抗体(BioLegend, 300324)被用于被用于流式细胞仪在人类样本上浓度为1:400. Cell (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Adv Sci (Weinh) (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 300440)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell Host Microbe (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 317331)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell Host Microbe (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:100
BioLegend CD3E抗体(Biolegend, 317332)被用于被用于流式细胞仪在人类样本上浓度为1:100. Immunity (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:50
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nature (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5). Arthritis Res Ther (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 344813)被用于被用于流式细胞仪在人类样本上. Aging (Albany NY) (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD3E抗体(Biolegend, 344818)被用于被用于流式细胞仪在人类样本上 (图 s2). Mucosal Immunol (2021) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2
BioLegend CD3E抗体(BioLegend, HIT3A)被用于被用于流式细胞仪在人类样本上 (图 2). Aging Cell (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1b
BioLegend CD3E抗体(Biolegend, 317343)被用于被用于流式细胞仪在人类样本上 (图 s1b). BMC Biol (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s4d
BioLegend CD3E抗体(Biolegend, 300402)被用于被用于流式细胞仪在人类样本上 (图 s4d). Science (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3b
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3b). Acta Neuropathol (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1b
BioLegend CD3E抗体(BioLegend, 300448)被用于被用于流式细胞仪在人类样本上 (图 s1b). Immunity (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, 300420)被用于被用于流式细胞仪在人类样本上. Cell (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, 344834)被用于被用于流式细胞仪在人类样本上. Science (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, 317347)被用于被用于流式细胞仪在人类样本上. Science (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:1000; 图 s1d
BioLegend CD3E抗体(Biolegend, 300425)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 s1d). Cell (2021) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:100
BioLegend CD3E抗体(Biolegend, 300318)被用于被用于流式细胞仪在人类样本上浓度为1:100. Science (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s2a
BioLegend CD3E抗体(Biolegend, 317324)被用于被用于流式细胞仪在人类样本上 (图 s2a). Cell (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s6-2
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 s6-2). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). Front Immunol (2020) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1). BMC Res Notes (2020) ncbi
小鼠 单克隆(OKT3)
  • 其他; 小鼠
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于其他在小鼠样本上. Nat Commun (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 300412)被用于被用于流式细胞仪在人类样本上. Nat Commun (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD3E抗体(BioLegend, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1b). Arthritis Res Ther (2020) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1s3b
BioLegend CD3E抗体(Biolegend, 317320)被用于被用于流式细胞仪在人类样本上 (图 1s3b). elife (2020) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:2000; 图 2j
BioLegend CD3E抗体(BioLegend, 300316)被用于被用于流式细胞仪在人类样本上浓度为1:2000 (图 2j). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3a
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3a). Aging (Albany NY) (2020) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3a
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3a). Aging (Albany NY) (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:25
BioLegend CD3E抗体(Biolegend, 300436)被用于被用于流式细胞仪在人类样本上浓度为1:25. bioRxiv (2020) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD3E抗体(Biolegend, 317340)被用于被用于流式细胞仪在人类样本上 (图 s2). Cell (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2s5a
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 2s5a). elife (2020) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 7s1b, 7s1c
BioLegend CD3E抗体(BioLegend, 317313)被用于被用于流式细胞仪在人类样本上 (图 7s1b, 7s1c). elife (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 3:50; 图 3j
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上浓度为3:50 (图 3j). Science (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s12a
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s12a). Nat Commun (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD3E抗体(BioLegend, 300406)被用于被用于流式细胞仪在人类样本上 (图 4b). Stem Cell Reports (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:200; 图 7a
BioLegend CD3E抗体(BioLegend, 300418)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7a). elife (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3c
BioLegend CD3E抗体(Biolegend, 300430)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell Rep (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 小鼠; 图 e9i
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在小鼠样本上 (图 e9i). Nature (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 7s1a
BioLegend CD3E抗体(Biolegend, 300448)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 7s1a). elife (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s14b
BioLegend CD3E抗体(Biolegend, Hit3a)被用于被用于流式细胞仪在人类样本上 (图 s14b). Science (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s6c
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 s6c). Science (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 e4f
BioLegend CD3E抗体(Biolegend, 300403)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 e4f). Nature (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:250; 图 6c
BioLegend CD3E抗体(BioLegend, 300405)被用于被用于流式细胞仪在人类样本上浓度为1:250 (图 6c). Nat Commun (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2d
BioLegend CD3E抗体(Biolegend, 300402)被用于被用于流式细胞仪在人类样本上 (图 s2d). Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3s2a
BioLegend CD3E抗体(Biolegend, 300454)被用于被用于流式细胞仪在人类样本上 (图 3s2a). elife (2019) ncbi
小鼠 单克隆(HIT3a)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 7d, 7f
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 7d, 7f). J Clin Invest (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 300420)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠; 图 s5b
BioLegend CD3E抗体(BioLegend, 300412)被用于被用于流式细胞仪在小鼠样本上 (图 s5b). Nat Immunol (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:200; 图 s7a
BioLegend CD3E抗体(Biolegend, 300424)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s7a). Nat Commun (2019) ncbi
小鼠 单克隆(UCHT1)
  • mass cytometry; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于mass cytometry在人类样本上. PLoS Pathog (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s2o
BioLegend CD3E抗体(Biolegend, 317324)被用于被用于流式细胞仪在人类样本上 (图 s2o). JCI Insight (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:200; 图 2a
  • 免疫细胞化学; 人类; 1:200; 图 2h
BioLegend CD3E抗体(Biolegend, 300415)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2a) 和 被用于免疫细胞化学在人类样本上浓度为1:200 (图 2h). elife (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6
BioLegend CD3E抗体(BioLegend, 300425)被用于被用于流式细胞仪在人类样本上 (图 6). Gastroenterol Res Pract (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:100; 图 s10a
BioLegend CD3E抗体(Biolegend, 344816)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s10a). Nat Commun (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3c
BioLegend CD3E抗体(Biolegend, 300448)被用于被用于流式细胞仪在人类样本上 (图 s3c). Cancer Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 其他; 人类; 图 4b
BioLegend CD3E抗体(BioLegend, 300475)被用于被用于其他在人类样本上 (图 4b). Cell (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(BioLegend, 300308)被用于被用于流式细胞仪在人类样本上 (图 4a). Diagn Pathol (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(BioLegend, 344822)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
BioLegend CD3E抗体(BioLegend, 300435)被用于被用于流式细胞仪在人类样本上 (表 1). J Exp Med (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2019) ncbi
小鼠 单克隆(UCHT1)
  • mass cytometry; 人类; 图 2b
BioLegend CD3E抗体(Biolegend, 300402)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s8
BioLegend CD3E抗体(BioLegend, HiT3A)被用于被用于流式细胞仪在人类样本上 (图 s8). Nat Commun (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 s1c, s2a
BioLegend CD3E抗体(Biolegend, 300410)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1c, s2a). Cancer Cell (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:100; 图 s1a, s3b
BioLegend CD3E抗体(Biolegend, 317328)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1a, s3b). Cancer Cell (2019) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 5 ug/ml; 图 s10e
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml (图 s10e). Nature (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, 300420)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(Biolegend, 300324)被用于被用于流式细胞仪在人类样本上 (图 2a). elife (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). Front Immunol (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s1a). Aging (Albany NY) (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:1; 图 s4
BioLegend CD3E抗体(BioLegend, 317330)被用于被用于流式细胞仪在人类样本上浓度为1:1 (图 s4). Nat Commun (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 9d
BioLegend CD3E抗体(BioLegend, 300312)被用于被用于流式细胞仪在人类样本上 (图 9d). J Exp Med (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s7a
BioLegend CD3E抗体(BioLegend, 300460)被用于被用于流式细胞仪在人类样本上 (图 s7a). Proc Natl Acad Sci U S A (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2a
  • 免疫细胞化学; 人类; 图 2d
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a) 和 被用于免疫细胞化学在人类样本上 (图 2d). Cell Stem Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 300406)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). Front Immunol (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). Am J Transplant (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 小鼠; 图 s14a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在小鼠样本上 (图 s14a). J Clin Invest (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3c
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3c). Transl Oncol (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 s5). Front Immunol (2018) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 8f
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 8f). J Clin Invest (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). J Virol (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD3E抗体(BioLegend, 300424)被用于被用于流式细胞仪在人类样本上 (图 1c). J Exp Med (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:100
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上浓度为1:100. Nature (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1c
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1c). J Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3). PLoS Pathog (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). Bone Marrow Transplant (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD3E抗体(Biolegend, 317328)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Clin Invest (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于抑制或激活实验在人类样本上 (图 1a). Eur J Immunol (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, 317329)被用于被用于流式细胞仪在人类样本上 (图 s1). Eur J Immunol (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, 300319)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell Rep (2018) ncbi
小鼠 单克隆(OKT3)
  • 免疫组化-石蜡切片; 人类; 图 6d
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6d). Cancer Res (2018) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 6a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 6a). FASEB J (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s4a
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Clin Invest (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 小鼠; 1:60; 图 7a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在小鼠样本上浓度为1:60 (图 7a). J Virol (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Am J Trop Med Hyg (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2c
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 2c). Nat Immunol (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). Int J Infect Dis (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 7d
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 7d). J Biol Chem (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD3E抗体(BioLegend, 300439)被用于被用于流式细胞仪在人类样本上 (图 7a). Cell (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 e1b
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 e1b). J Allergy Clin Immunol (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2e
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 2e). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2e
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2e). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6c
BioLegend CD3E抗体(BioLegend, 300429)被用于被用于流式细胞仪在人类样本上 (图 6c). Immunity (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 7c
BioLegend CD3E抗体(BioLegend, 300316)被用于被用于流式细胞仪在人类样本上 (图 7c). Immunity (2017) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 图 2c
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于抑制或激活实验在人类样本上 (图 2c). Oncotarget (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 s3
BioLegend CD3E抗体(biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (表 s3). Cell (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). J Exp Med (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 300406)被用于被用于流式细胞仪在人类样本上 (图 1a). F1000Res (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5a
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5a). Cancer Res (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上. Cancer Res (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, 300318)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, 344814)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 5a). FEBS Lett (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Cell Biol (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 3d
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 3d). Clin Exp Immunol (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s1a). JCI Insight (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3a). Sci Rep (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(Biolegend, 300434)被用于被用于流式细胞仪在人类样本上 (图 4a). Sci Rep (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 2a
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 2a) 和 被用于流式细胞仪在人类样本上 (图 2a). Leukemia (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 1
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4b). J Virol (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, 317306)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol Methods (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s4a
BioLegend CD3E抗体(BioLegend, Okt3)被用于被用于抑制或激活实验在人类样本上 (图 s4a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s1). PLoS ONE (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(Biolegend, 300424)被用于被用于流式细胞仪在人类样本上 (图 4a). J Virol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 s1). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(HIT3a)
  • 免疫细胞化学; 人类; 图 s9
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于免疫细胞化学在人类样本上 (图 s9). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于抑制或激活实验在人类样本上. Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s7
BioLegend CD3E抗体(Biolegend, 317332)被用于被用于流式细胞仪在人类样本上 (图 s7). Cell (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 5a
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 5a). Clin Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 4b). J Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD3E抗体(BioLegend, 300317)被用于被用于流式细胞仪在人类样本上 (图 7a). J Exp Clin Cancer Res (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s6a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s6a). J Clin Invest (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s5a
BioLegend CD3E抗体(Biolegend, 300329)被用于被用于流式细胞仪在人类样本上 (图 s5a). Sci Rep (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Negl Trop Dis (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 7
BioLegend CD3E抗体(Biolegend, 317328)被用于被用于流式细胞仪在人类样本上 (图 7). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2a
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2a). Eur J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). Cytotherapy (2016) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于抑制或激活实验在人类样本上. Cytotherapy (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2
BioLegend CD3E抗体(BioLegend, HIT-3a)被用于被用于流式细胞仪在人类样本上 (图 2). JCI Insight (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3). Nature (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Nat Immunol (2016) ncbi
小鼠 单克隆(OKT3)
BioLegend CD3E抗体(Biolegend, 317302)被用于. Nat Commun (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1d). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1b). Arthritis Rheumatol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:100; 图 5
BioLegend CD3E抗体(Biolegend, 300305)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(UCHT1)
BioLegend CD3E抗体(Biolegend, 300440)被用于. Sci Rep (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD3E抗体(biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1d). Oncotarget (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100. PLoS ONE (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, 300318)被用于被用于流式细胞仪在人类样本上. Haematologica (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 小鼠; 图 3
BioLegend CD3E抗体(Biolegend, 3000316)被用于被用于流式细胞仪在小鼠样本上 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 st1
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 st1). J Autoimmun (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD3E抗体(Biolegend, 300310)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠; 1:100
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Commun (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS Pathog (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 7.45.3
BioLegend CD3E抗体(BioLegend, 344827)被用于被用于流式细胞仪在人类样本上 (图 7.45.3). Curr Protoc Cytom (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD3E抗体(BioLegend, 300317)被用于被用于流式细胞仪在人类样本上 (图 4b). J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
BioLegend CD3E抗体(BioLegend, 300418)被用于. PLoS ONE (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 8b
BioLegend CD3E抗体(Biolegend, 300406)被用于被用于流式细胞仪在人类样本上 (图 8b). PLoS ONE (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 小鼠
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在小鼠样本上. PLoS Pathog (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4). Leukemia (2016) ncbi
小鼠 单克隆(SK7)
  • 免疫组化-冰冻切片; 人类; 1:50; 图 6
BioLegend CD3E抗体(Biolegend, 344802)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:50 (图 6). Nat Commun (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
BioLegend CD3E抗体(Biolegend, 300434)被用于被用于流式细胞仪在人类样本上 (图 1). Allergy (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 300417)被用于被用于流式细胞仪在人类样本上. J Vis Exp (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS Pathog (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, 300330)被用于被用于流式细胞仪在人类样本上. Am J Reprod Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 300420)被用于被用于流式细胞仪在人类样本上. Cancer Lett (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上. Thromb Res (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 表 2
BioLegend CD3E抗体(Biolegend, 300312)被用于被用于流式细胞仪在人类样本上 (表 2). Exp Cell Res (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2). J Hematol Oncol (2015) ncbi
小鼠 单克隆(UCHT1)
BioLegend CD3E抗体(Biolegend, UCHT1)被用于. Clin Exp Immunol (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200; 图 s3
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200
BioLegend CD3E抗体(Biolegend, OKT)被用于被用于流式细胞仪在人类样本上浓度为1:200. J Immunol Methods (2015) ncbi
小鼠 单克隆(OKT3)
BioLegend CD3E抗体(biolegend, 317323)被用于. PLoS Pathog (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3
BioLegend CD3E抗体(Biolegend, # 300431)被用于被用于流式细胞仪在人类样本上 (图 3). Biomaterials (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3
BioLegend CD3E抗体(Biolegend, #344826)被用于被用于流式细胞仪在人类样本上 (图 3). Cell Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3,4,5
BioLegend CD3E抗体(Biolegend, 300431)被用于被用于流式细胞仪在人类样本上 (图 3,4,5). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s7
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 s7). PLoS ONE (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, clone UCHT1)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, #300425)被用于被用于流式细胞仪在人类样本上. Immunol Invest (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 317306)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 344808)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, 300317)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
BioLegend CD3E抗体(Biolegend, UCH1)被用于被用于流式细胞仪在人类样本上 (图 4). Infect Immun (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 2:100; 图 7
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为2:100 (图 7). Nat Commun (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4). J Exp Med (2015) ncbi
小鼠 单克隆(SK7)
  • 免疫细胞化学; 人类; 图 8a
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于免疫细胞化学在人类样本上 (图 8a). J Cell Biol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在人类样本上 (图 s3). Blood (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, HIT3a)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
BioLegend CD3E抗体(BioLegend, OKT3)被用于被用于抑制或激活实验在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3S
BioLegend CD3E抗体(Biolegend, 300316)被用于被用于流式细胞仪在人类样本上 (图 3S). PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
BioLegend CD3E抗体(Biolegend, 300431)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS Pathog (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, SK7)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 0.5 ug/ml
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为0.5 ug/ml. Sci Rep (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 小鼠; 图 1
BioLegend CD3E抗体(Biolegend, SK7)被用于被用于流式细胞仪在小鼠样本上 (图 1). Leukemia (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Cell Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, clone OKT3)被用于被用于流式细胞仪在人类样本上. Mol Ther (2014) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 黑猩猩
BioLegend CD3E抗体(BioLegend, HIT3a)被用于被用于抑制或激活实验在黑猩猩样本上. J Med Primatol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(Biolegend, OKT3)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
BioLegend CD3E抗体(BioLegend, UCHT-1)被用于被用于流式细胞仪在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 染色质免疫沉淀 ; 人类
  • 免疫印迹; 人类; 图 4a
BioLegend CD3E抗体(BioLegend, UCHT-1)被用于被用于染色质免疫沉淀 在人类样本上 和 被用于免疫印迹在人类样本上 (图 4a). J Immunol (2013) ncbi
赛默飞世尔
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 1:500; 图 3c
赛默飞世尔 CD3E抗体(THERMOFISHER, MA5-14,524)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 3c). Sci Rep (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200; 图 s3a
赛默飞世尔 CD3E抗体(Invitrogen, 47-0037-41)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s3a). Nature (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:40
赛默飞世尔 CD3E抗体(ThermoFisher Scientific, 45-0037-42)被用于被用于流式细胞仪在人类样本上浓度为1:40. elife (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5b
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5b). ACS Synth Biol (2021) ncbi
小鼠 单克隆(UCHT1)
  • 其他; 人类; 图 s4-1e
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, 16-0038-85)被用于被用于其他在人类样本上 (图 s4-1e). elife (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(eBioscience, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1b). Arthritis Res Ther (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD3E抗体(Invitrogen, 47-0037-41)被用于被用于流式细胞仪在人类样本上 (图 s3). Nature (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200; 图 e4a
赛默飞世尔 CD3E抗体(Invitrogen, 47-0037-41)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 e4a). Nature (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:20; 图 s11
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s11). Science (2021) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(eBioscience, OKT4)被用于被用于流式细胞仪在人类样本上 (图 4). Aging Cell (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6c
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 6c). Cell Death Dis (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, 11-0036-42)被用于被用于流式细胞仪在人类样本上. Cancer Sci (2021) ncbi
小鼠 单克隆(UCHT1)
  • 免疫印迹; 人类; 1:50; 图 s8a
赛默飞世尔 CD3E抗体(Thermo Fisher, 56-0038-42)被用于被用于免疫印迹在人类样本上浓度为1:50 (图 s8a). Science (2020) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 1:50; 图 1s3b
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, MHCD0304)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1s3b). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD3E抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Science (2020) ncbi
小鼠 单克隆(F7.2.38)
  • 免疫组化; 小鼠; 图 3e
赛默飞世尔 CD3E抗体(ThermoFisher Scientific, F7.2.38)被用于被用于免疫组化在小鼠样本上 (图 3e). Nat Commun (2020) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 7j
赛默飞世尔 CD3E抗体(Invitrogen, 7D6)被用于被用于流式细胞仪在人类样本上 (图 7j). J Exp Med (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3s1
赛默飞世尔 CD3E抗体(eBioscience, 11-0038-42)被用于被用于流式细胞仪在人类样本上 (图 3s1). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠; 1:100; 图 5a
赛默飞世尔 CD3E抗体(eBioscience, 15003842)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 5a). Nat Commun (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1c
赛默飞世尔 CD3E抗体(eBioscience, 48-0037-41)被用于被用于流式细胞仪在人类样本上 (图 s1c). Cell (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 CD3E抗体(eBioscience, 17-0036-42)被用于被用于流式细胞仪在人类样本上 (图 s1a). BMC Cancer (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3f, 3g
赛默飞世尔 CD3E抗体(Invitrogen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3f, 3g). Brain Pathol (2020) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2 ug/ml; 图 4a
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上浓度为2 ug/ml (图 4a). Diagn Pathol (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 猕猴; 1:200; 图 3g
赛默飞世尔 CD3E抗体(Invitrogen, 47-0037-41)被用于被用于流式细胞仪在猕猴样本上浓度为1:200 (图 3g). Nature (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200; 图 2s1b
赛默飞世尔 CD3E抗体(eBioscience, 45-0037-71)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2s1b). elife (2019) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3b
赛默飞世尔 CD3E抗体(Themo, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3b). elife (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2019) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:150; 图 s4a
赛默飞世尔 CD3E抗体(Thermofisher, MA1-90582)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (图 s4a). Cancer Cell (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Immunol Cell Biol (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD3E抗体(eBioscience, 45-0036)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2a
赛默飞世尔 CD3E抗体(生活技术, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2a). Nat Med (2019) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 s2a
赛默飞世尔 CD3E抗体(生活技术, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2a). Nat Med (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s18b
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s18b). Science (2018) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 1:20; 图 2m
赛默飞世尔 CD3E抗体(Thermo Fisher, SP7)被用于被用于免疫组化在小鼠样本上浓度为1:20 (图 2m). J Exp Med (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3i
赛默飞世尔 CD3E抗体(eBiosciences, 13-0037-82)被用于被用于流式细胞仪在人类样本上 (图 s3i). Cell (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s4a
赛默飞世尔 CD3E抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s4a). Sci Immunol (2018) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 3b
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, Sp7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3b). J Clin Invest (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1b). J Clin Invest (2018) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 2b
赛默飞世尔 CD3E抗体(ThermoFisher, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2b). Cell (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD3E抗体(ebioscience, 16-0037)被用于被用于流式细胞仪在人类样本上 (图 2c). Cell Death Dis (2017) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 小鼠; 图 3b
赛默飞世尔 CD3E抗体(生活技术, MHCD0301)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Cell Stem Cell (2017) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 s1). Eur J Immunol (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD3E抗体(eBioscience, 11-0037-42)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD3E抗体(eBioscience, 13-0038-82)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 6d
赛默飞世尔 CD3E抗体(ebioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 6d). PLoS ONE (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:200; 图 4a
赛默飞世尔 CD3E抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 4a). Front Immunol (2017) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类; 图 1e
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上 (图 1e). J Clin Invest (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (表 1). Cell (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD3E抗体(eBioscience, 48-0038-42)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncoimmunology (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 30 ng/ml; 图 s9
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为30 ng/ml (图 s9). Nature (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3e
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, 48-0038)被用于被用于流式细胞仪在人类样本上 (图 3e). Cell Res (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, 11-0039)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell Res (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔 CD3E抗体(eBioscience, 11-0038)被用于被用于流式细胞仪在人类样本上 (图 4b). Cell (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD3E抗体(eBioscience, OKT-3)被用于被用于流式细胞仪在人类样本上 (图 2a). Oncoimmunology (2017) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-冰冻切片; 猕猴; 图 2a
赛默飞世尔 CD3E抗体(Thermo Fischer, CD3-12)被用于被用于免疫组化-冰冻切片在猕猴样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Med Princ Pract (2017) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 5
赛默飞世尔 CD3E抗体(Thermo Fischer Scientific, MA5-14524)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 5). Oncotarget (2017) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 小鼠; 图 s4
赛默飞世尔 CD3E抗体(Invitrogen, 7D6)被用于被用于流式细胞仪在小鼠样本上 (图 s4). J Clin Invest (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 图 s1b
赛默飞世尔 CD3E抗体(ThermoFisher, RM9107)被用于被用于免疫组化在小鼠样本上 (图 s1b). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(ebioscience, HIT3a)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(OKT3)
  • 免疫细胞化学; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-81)被用于被用于免疫细胞化学在人类样本上 (表 1). J Vis Exp (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD3E抗体(eBiosciences, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2c). PLoS Pathog (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于. Leukemia (2017) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0317)被用于被用于流式细胞仪在人类样本上 (图 1c). Genome Biol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 1e
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1e). Glia (2017) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-冰冻切片; 人类; 1:150; 图 2b
赛默飞世尔 CD3E抗体(Thermo-Fisher, SP7)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:150 (图 2b). J Proteome Res (2017) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 2a
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a). Immunol Cell Biol (2017) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, 7D6)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 s1a
赛默飞世尔 CD3E抗体(实验室视觉, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s1a). Am J Pathol (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Clin Cancer Res (2017) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于. AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2.5 ug/ml; 图 7d
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml (图 7d). Mol Biol Cell (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 6a
赛默飞世尔 CD3E抗体(eBiosciences, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 6a). Mol Biol Cell (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上. Cell Death Dis (2016) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. elife (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 1
赛默飞世尔 CD3E抗体(Thermo Fisher, RM9107-S1)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Clin Exp Metastasis (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD3E抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 s3a
赛默飞世尔 CD3E抗体(eBiosciences, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 s3a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于. PLoS ONE (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 6
赛默飞世尔 CD3E抗体(Thermo Scientific, MA5-14524)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6). JCI Insight (2016) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化; 人类; 1:200; 图 5d
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于免疫组化在人类样本上浓度为1:200 (图 5d). Mol Cancer Res (2016) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 2). J Transl Med (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s1c
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s1c). Oncotarget (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 1). Oncotarget (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 S1
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 S1). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1)
  • mass cytometry; 人类; 表 1, 2
赛默飞世尔 CD3E抗体(生活技术, UCHT1)被用于被用于mass cytometry在人类样本上 (表 1, 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3). PLoS ONE (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s2a
  • 免疫组化-石蜡切片; 人类; 图 4b
赛默飞世尔 CD3E抗体(eBioscience, EB16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 s2a) 和 被用于免疫组化-石蜡切片在人类样本上 (图 4b). J Immunother Cancer (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, CD0330)被用于被用于流式细胞仪在人类样本上. Haematologica (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 s2b
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 s2b). PLoS ONE (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, 48-0038-42)被用于被用于流式细胞仪在人类样本上. Oncoimmunology (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 流式细胞仪; 小鼠; 1:150; 图 4
赛默飞世尔 CD3E抗体(Thermo Fischer Scientific, SP7)被用于被用于流式细胞仪在小鼠样本上浓度为1:150 (图 4). J Intern Med (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 8
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 8). J Exp Med (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 5
赛默飞世尔 CD3E抗体(Thermo Scientific, MA1-90582)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 1:200; 图 4
赛默飞世尔 CD3E抗体(Neomarkers, RM-9107-5)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 4). Peerj (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 4b
赛默飞世尔 CD3E抗体(Thermo Fisher, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 4b). J Thorac Oncol (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(eBioscience, OKT-3)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫印迹; 大鼠; 1:100; 图 13
赛默飞世尔 CD3E抗体(Thermo Scientific, RM9107)被用于被用于免疫印迹在大鼠样本上浓度为1:100 (图 13). Nat Med (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于. Immunol Res (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 2
赛默飞世尔 CD3E抗体(eBioscence, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1
赛默飞世尔 CD3E抗体(Thermo Fisher, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1). APMIS (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS Pathog (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:2000; 图 1
赛默飞世尔 CD3E抗体(Neomarkers, RM-9107-S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:2000 (图 1). Acta Neuropathol Commun (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (2016) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0317)被用于被用于流式细胞仪在人类样本上 (图 1). elife (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 1c
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1c). J Exp Clin Cancer Res (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD3E抗体(Tonbo, 25-0038)被用于被用于流式细胞仪在人类样本上 (图 3). Nat Commun (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 1c
赛默飞世尔 CD3E抗体(Labvision, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1c). Nat Med (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 7). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 酶联免疫吸附测定; 人类; 图 2
赛默飞世尔 CD3E抗体(eBioscience, 16?C0039)被用于被用于酶联免疫吸附测定在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在小鼠样本上. Nat Chem Biol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 e3d
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 e3d). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 e3d
赛默飞世尔 CD3E抗体(eBioscience, (HIT3A)被用于被用于流式细胞仪在人类样本上 (图 e3d). J Allergy Clin Immunol (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:250; 表 1
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (表 1). Medicine (Baltimore) (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 1). MAbs (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上. Respir Res (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 6a
赛默飞世尔 CD3E抗体(Thermo, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6a). Clin Exp Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD3E抗体(Invitrogen, Q10054)被用于被用于流式细胞仪在人类样本上 (图 3a). Hum Vaccin Immunother (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 6c
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 6c). Nat Immunol (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s5
赛默飞世尔 CD3E抗体(eBiosciences, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 s5). Nat Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Kidney Int (2015) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Kidney Int (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). J Neuroinflammation (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 s1
赛默飞世尔 CD3E抗体(Thermo, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s1). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 图 4a
赛默飞世尔 CD3E抗体(Thermo Scientific, MA1?C90582)被用于被用于免疫组化在人类样本上 (图 4a). Oncoimmunology (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1b). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD3E抗体(eBioscience, HIT3A)被用于被用于流式细胞仪在人类样本上 (图 s3). J Exp Med (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3). J Exp Med (2015) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 4). J Cell Biol (2015) ncbi
小鼠 单克隆(MEM-57)
  • 免疫组化; 人类; 1:200
赛默飞世尔 CD3E抗体(Thermo Scientific, MA1-19454)被用于被用于免疫组化在人类样本上浓度为1:200. Histochem Cell Biol (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 CD3E抗体(生活技术, PA1-37282)被用于. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP7)被用于被用于免疫组化在人类样本上. World J Urol (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, 48-0037-42)被用于被用于流式细胞仪在人类样本上. Blood Cancer J (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 10 ng/ml; 图 1
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为10 ng/ml (图 1). J Chin Med Assoc (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Immunol (2015) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Immunol (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 猕猴; 1:100
赛默飞世尔 CD3E抗体(Lab Vision/NeoMarkers, SP7)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:100. PLoS ONE (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 6). Bone Marrow Transplant (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 7.5 ug/ml; 图 6a
赛默飞世尔 CD3E抗体(Thermo Scientific, RM-9107-S)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为7.5 ug/ml (图 6a). Vet Pathol (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 图 4h
赛默飞世尔 CD3E抗体(ThermoFischer, SP7)被用于被用于免疫组化在人类样本上 (图 4h). Eur J Hum Genet (2016) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:300; 图 1
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP-7)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:300 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1b). Clin Cancer Res (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1b). Clin Cancer Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 5 ug/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml. J Virol (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫沉淀; 小鼠
  • 免疫组化; 人类
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫沉淀在小鼠样本上 和 被用于免疫组化在人类样本上. Dig Dis Sci (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:100
赛默飞世尔 CD3E抗体(Lab Vision, SP7)被用于被用于免疫组化在人类样本上浓度为1:100. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 图 3
赛默飞世尔 CD3E抗体(Thermo Scientific, RM9107-s)被用于被用于免疫组化在小鼠样本上 (图 3). Cancer Biol Ther (2015) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, 48-0038)被用于被用于流式细胞仪在人类样本上. Cancer Res (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠; 1:100; 图 s3a
赛默飞世尔 CD3E抗体(Neomarkers, RM9107)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s3a). Nat Commun (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2015) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 3
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 3). Cancer Immunol Res (2015) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0306)被用于被用于流式细胞仪在人类样本上. Nat Commun (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Cell Biol (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:25; 图 2d
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, RM9107S)被用于被用于免疫组化在人类样本上浓度为1:25 (图 2d). elife (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 表 1
赛默飞世尔 CD3E抗体(NeoMarkers, RM 9107)被用于被用于免疫组化-石蜡切片在小鼠样本上 (表 1). Methods Mol Biol (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 0.5 ug/ml
赛默飞世尔 CD3E抗体(eBIoscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml. J Biol Chem (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-自由浮动切片; 人类
赛默飞世尔 CD3E抗体(Lab Vision, SP7)被用于被用于免疫组化-自由浮动切片在人类样本上. Arthritis Rheumatol (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 小鼠; 1:2000
赛默飞世尔 CD3E抗体(Invitrogen, S4.1PB)被用于被用于流式细胞仪在小鼠样本上浓度为1:2000. Stem Cell Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:150
赛默飞世尔 CD3E抗体(Thermo Scientific Labvision, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150. J Am Acad Dermatol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6g
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 6g). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(e-Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD3E抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (表 1). J Gen Virol (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2 ug/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为2 ug/ml. PLoS Negl Trop Dis (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上. Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:150
赛默飞世尔 CD3E抗体(THERMO SC, SP7)被用于被用于免疫组化在人类样本上浓度为1:150. BMC Clin Pathol (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 图 4
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP7)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). J Exp Med (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 50 ng/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上浓度为50 ng/ml. J Leukoc Biol (2014) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Med Microbiol Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, 45-0037-42)被用于被用于流式细胞仪在人类样本上. Gut Microbes (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:2000
赛默飞世尔 CD3E抗体(Neomarkers, RM-9107-S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:2000. J Neurol Neurosurg Psychiatry (2014) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0317)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBiosciences, OKT3)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 小鼠; 1:200
赛默飞世尔 CD3E抗体(Labvision, RM-9107-S0)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200. Mucosal Immunol (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD3E抗体(Fisher/Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(e-Biosciences, OKT-3)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上. J Transl Med (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 免疫细胞化学; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于免疫细胞化学在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. Cancer Res (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD3E抗体(Thermo Fisher Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上. Circ Arrhythm Electrophysiol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, 14-0037-82)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:100
赛默飞世尔 CD3E抗体(Labvision/Thermo Scientific, SP7)被用于被用于免疫组化在人类样本上浓度为1:100. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫细胞化学; 人类; 1:100
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫细胞化学在人类样本上浓度为1:100. J Crohns Colitis (2014) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 3 ug/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为3 ug/ml. J Immunol (2014) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, UCHT1)被用于被用于流式细胞仪在人类样本上. Retrovirology (2014) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(Ebioscience, UCHT1)被用于被用于抑制或激活实验在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 0.5 ug/ml; 图 1
赛默飞世尔 CD3E抗体(eBioscience, HIT3a)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml (图 1). Ann Rheum Dis (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于. J Infect Dis (2014) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1
赛默飞世尔 CD3E抗体(Lab Vision, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1). J Neuropathol Exp Neurol (2013) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:10; 图 4
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 4). Drug Metab Dispos (2014) ncbi
小鼠 单克隆(7D6)
  • 抑制或激活实验; 人类
  • 免疫印迹; 人类; 图 5
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于抑制或激活实验在人类样本上 和 被用于免疫印迹在人类样本上 (图 5). J Virol (2013) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2014) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Eur J Immunol (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Eur J Immunol (2013) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:2000; 图 1
赛默飞世尔 CD3E抗体(Neomarkers, RM-9107-S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:2000 (图 1). Brain (2013) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. J Med Genet (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, clone UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Vaccine (2013) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, noca)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2013) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD3E抗体(Invitrogen, clone S4.1)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2013) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 4). J Investig Allergol Clin Immunol (2012) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2013) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. BMC Immunol (2013) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:150; 表 2
赛默飞世尔 CD3E抗体(Labvision, SP7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (表 2). PLoS ONE (2012) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cells (2013) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(CALTAG, MHCD0305)被用于被用于流式细胞仪在人类样本上 (图 2). Clin Immunol (2012) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-冰冻切片; 小鼠; 1:50; 图 s3
赛默飞世尔 CD3E抗体(Thermoscientific, RM-9107-S1)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:50 (图 s3). PLoS Pathog (2012) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2012) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2012) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Invitrogen, clone UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2). Vaccine (2012) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(Invitrogen, MHCD0317)被用于被用于流式细胞仪在人类样本上 (图 4). PLoS ONE (2012) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 5). J Immunol (2012) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:100; 图 1
赛默飞世尔 CD3E抗体(Thermo Scientific, RM-9107-S1)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1). PLoS Pathog (2012) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 小鼠
赛默飞世尔 CD3E抗体(Neomarkers, RM9107)被用于被用于免疫组化在小鼠样本上. Oncotarget (2011) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:150; 图 2
赛默飞世尔 CD3E抗体(Lab Vision, RM-9107)被用于被用于免疫组化在人类样本上浓度为1:150 (图 2). Breast Cancer Res (2011) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBiosciences, UHCT1)被用于被用于流式细胞仪在人类样本上. Blood (2011) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2.5 ug/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml. PLoS ONE (2011) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类
  • 免疫组化; 人类
赛默飞世尔 CD3E抗体(Thermo Scientific, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 和 被用于免疫组化在人类样本上. Hum Pathol (2012) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 S2
赛默飞世尔 CD3E抗体(eBioscience, 46-0037-42)被用于被用于流式细胞仪在人类样本上 (图 S2). Proc Natl Acad Sci U S A (2012) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:150; 图 5C
赛默飞世尔 CD3E抗体(Thermo Scientific, RM-9107-S1)被用于被用于免疫组化在人类样本上浓度为1:150 (图 5C). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 5). Front Microbiol (2011) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 1:150; 表 2
赛默飞世尔 CD3E抗体(Lab vision, RM-9107)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (表 2). Breast Cancer (Auckl) (2011) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类
  • 免疫组化; 人类
赛默飞世尔 CD3E抗体(Thermo, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 和 被用于免疫组化在人类样本上. Int J Surg Pathol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). EMBO Mol Med (2011) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔 CD3E抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). EMBO Mol Med (2011) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Caltag, MHCD0318)被用于被用于流式细胞仪在人类样本上 (图 2). Biotechnol Bioeng (2011) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, clone UHCT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2011) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag, MHCD0306)被用于被用于流式细胞仪在人类样本上 (图 1). Scand J Immunol (2011) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 3
赛默飞世尔 CD3E抗体(Invitrogen, clone UCHT1)被用于被用于流式细胞仪在人类样本上 (表 3). Vaccine (2011) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-石蜡切片; 人类; 图 3
  • 免疫组化; 人类
赛默飞世尔 CD3E抗体(Thermo Fisher, SP7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3) 和 被用于免疫组化在人类样本上. J Endocrinol (2011) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2). Immunobiology (2011) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag/Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2010) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在小鼠样本上 (图 3). Blood (2010) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(eBioscience, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2010) ncbi
小鼠 单克隆(7D6)
  • 其他; 人类; 图 2
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于其他在人类样本上 (图 2). J Immunol Methods (2010) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Arthritis Rheum (2010) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). Hum Immunol (2010) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, MHCD0304)被用于被用于流式细胞仪在人类样本上. Lupus (2010) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 1:20; 图 3
赛默飞世尔 CD3E抗体(CalTag, clone MHCD0304)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 3). J Pathol (2009) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, noca)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2009) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag/Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. Nat Protoc (2008) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD3E抗体(eBioscience, 15-0038)被用于被用于流式细胞仪在人类样本上 (表 1). Med Oncol (2010) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:150; 图 1
赛默飞世尔 CD3E抗体(Lab Vision, RM-9107)被用于被用于免疫组化在人类样本上浓度为1:150 (图 1). PLoS ONE (2008) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
  • 流式细胞仪; 猕猴; 图 4
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4) 和 被用于流式细胞仪在猕猴样本上 (图 4). J Virol (2008) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Lupus (2008) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2008) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2008) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. Blood (2008) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 2a). Int J Tuberc Lung Dis (2008) ncbi
小鼠 单克隆(7D6)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(Invitrogen, S4.1)被用于被用于抑制或激活实验在人类样本上. Toxicol Appl Pharmacol (2008) ncbi
小鼠 单克隆(7D6)
  • 抑制或激活实验; 人类; 100 ng/ml; 图 3c
赛默飞世尔 CD3E抗体(Caltag/Invitrogen, S4.1)被用于被用于抑制或激活实验在人类样本上浓度为100 ng/ml (图 3c). Gene Ther (2007) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(CalTag, MHCD0306)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2007) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Virol (2007) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2007) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Leukemia (2007) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Blood (2007) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 0.5 ug/ml
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml. PLoS ONE (2006) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(eBioscience, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2006) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT-3)被用于被用于抑制或激活实验在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2006) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Immunol Lett (2006) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 s1). Blood (2006) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. J Virol (2005) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (表 2). Eur J Immunol (2005) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2006) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Mol Hum Reprod (2005) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry A (2005) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; African green monkey; 图 1
赛默飞世尔 CD3E抗体(Caltag Laboratories, S4.1)被用于被用于流式细胞仪在African green monkey样本上 (图 1). J Immunol Methods (2005) ncbi
小鼠 单克隆(SPV-T3b)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Zymed, SPV-T3b)被用于被用于流式细胞仪在人类样本上 (图 2). Eur J Immunol (2005) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD3E抗体(Caltag Laboratories, S4.1)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol Methods (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Transfusion (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, MHCD0301)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD3E抗体(CALTAG, S4.1)被用于被用于流式细胞仪在人类样本上 (表 1). Am J Reprod Immunol (2004) ncbi
小鼠 单克隆(SPV-T3b)
  • 抑制或激活实验; 人类; 1 ug/ml
赛默飞世尔 CD3E抗体(Zymed, SPV-T3b)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Eur J Immunol (2004) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Zymed, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(7D6)
  • 免疫组化-冰冻切片; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag Laboratories, clone S4.1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1). AIDS (2003) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (表 2). Transfusion (2003) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Immunol (2003) ncbi
小鼠 单克隆(SPV-T3b)
  • 免疫组化-石蜡切片; 人类; 图 4
赛默飞世尔 CD3E抗体(Zymed, 070303)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4). Nat Med (2003) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2002) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2002) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2002) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 4 ug/ml
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上浓度为4 ug/ml. Blood (2001) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2001) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD3E抗体(Caltag Laboratories, clone S4.1)被用于被用于流式细胞仪在人类样本上 (图 3). Cytometry (2001) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2001) ncbi
小鼠 单克隆(SPV-T3b)
  • 其他; 牛
赛默飞世尔 CD3E抗体(Zymed, SPV-T3b)被用于被用于其他在牛样本上. Thyroid (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Cytometry (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD3E抗体(Caltag, clone S4.1)被用于被用于流式细胞仪在人类样本上 (表 2). J Immunol Methods (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Clin Diagn Lab Immunol (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 表 5
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (表 5). Transfusion (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4-1)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. Infect Immun (2000) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 小鼠
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在小鼠样本上. J Immunol (1999) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上. J Immunol (1999) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (1998) ncbi
小鼠 单克隆(7D6)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于流式细胞仪在人类样本上 (图 5). Blood (1998) ncbi
小鼠 单克隆(7D6)
  • 免疫细胞化学; 人类; 图 3
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于免疫细胞化学在人类样本上 (图 3). Stem Cells (1997) ncbi
小鼠 单克隆(7D6)
  • 免疫细胞化学; 人类; 图 2
赛默飞世尔 CD3E抗体(Caltag, S4.1)被用于被用于免疫细胞化学在人类样本上 (图 2). J Leukoc Biol (1997) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 免疫沉淀; 人类; 图 3
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫沉淀在人类样本上 (图 3). J Biol Chem (1983) ncbi
小鼠 单克隆(7D6)
  • 免疫沉淀; 人类; 图 3
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫沉淀在人类样本上 (图 3). J Biol Chem (1983) ncbi
小鼠 单克隆(S4.1)
  • 免疫沉淀; 人类; 图 3
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫沉淀在人类样本上 (图 3). J Biol Chem (1983) ncbi
小鼠 单克隆(UCH-T1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(noco, UCHT1)被用于被用于流式细胞仪在人类样本上. Cell (1986) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD3E抗体(noco, UCHT1)被用于被用于流式细胞仪在人类样本上. Cell (1986) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 免疫印迹; 人类
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫印迹在人类样本上. Nature (1986) ncbi
小鼠 单克隆(7D6)
  • 免疫印迹; 人类
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫印迹在人类样本上. Nature (1986) ncbi
小鼠 单克隆(S4.1)
  • 免疫印迹; 人类
赛默飞世尔 CD3E抗体(noco, noca)被用于被用于免疫印迹在人类样本上. Nature (1986) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 s6e
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 s6e). Theranostics (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 s1c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, AB5690)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 s1c). Proc Natl Acad Sci U S A (2021) ncbi
仓鼠 单克隆(145-2C11)
  • 流式细胞仪; 小鼠; 图 7c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, 145-2C11)被用于被用于流式细胞仪在小鼠样本上 (图 7c). J Clin Invest (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 大鼠; 1:100; 图 7e
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:100 (图 7e). Front Cell Neurosci (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 1:250
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化在小鼠样本上浓度为1:250. Animals (Basel) (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 1:200; 图 4d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 4d). elife (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在人类样本上. Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 2d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2d). Aging Cell (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 猕猴; 2 ug/ml; 图 s8b
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为2 ug/ml (图 s8b). Science (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, AB5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4a). Cell (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 4c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 4c). Transl Oncol (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-冰冻切片; 猕猴; 1:100; 图 5i
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化-冰冻切片在猕猴样本上浓度为1:100 (图 5i). Mol Ther Methods Clin Dev (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 s13f
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在小鼠样本上 (图 s13f). Science (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 人类; 图 s7d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s7d). Cell (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 e3e
  • 免疫组化-石蜡切片; 人类; 图 e9a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, CD3-12)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 e3e) 和 被用于免疫组化-石蜡切片在人类样本上 (图 e9a). Nature (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). BMC Nephrol (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 s6b
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s6b). Science (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 图 2a, 3a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, CD3-C12)被用于被用于免疫组化在小鼠样本上 (图 2a, 3a). J Immunol (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3d
艾博抗(上海)贸易有限公司 CD3E抗体(AbCam, ab11089)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3d). Pulm Circ (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2c). Oncoimmunology (2018) ncbi
domestic rabbit 单克隆
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, 133628)被用于被用于免疫印迹在人类样本上 (图 2c). J Immunol (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 1:200; 图 7a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在大鼠样本上浓度为1:200 (图 7a). PLoS ONE (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 38
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在小鼠样本上 (图 38). J Toxicol Pathol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 4d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab16044)被用于被用于免疫组化在小鼠样本上 (图 4d). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 s6b
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s6b). Nature (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 1j
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在小鼠样本上 (图 1j). Cell Mol Gastroenterol Hepatol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:250; 图 4c
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:250 (图 4c). Mol Vis (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 5a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4d). Dis Model Mech (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab16044)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3). BMC Complement Altern Med (2016) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 8a
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab11089)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 8a). NMR Biomed (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:150; 图 s6q
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:150 (图 s6q). Nature (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:75; 图 3e
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, Ab5690)被用于被用于免疫组化在小鼠样本上浓度为1:75 (图 3e). Gut (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:50; 图 6
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:50 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 5
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, Ab5690)被用于被用于免疫组化在小鼠样本上 (图 5). Nat Cell Biol (2016) ncbi
小鼠 单克隆(PS1)
  • 免疫组化-冰冻切片; 人类; 图 s4b
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab699)被用于被用于免疫组化-冰冻切片在人类样本上 (图 s4b). Arthritis Res Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:250; 图 5b
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在小鼠样本上浓度为1:250 (图 5b). Mol Vis (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 3e
艾博抗(上海)贸易有限公司 CD3E抗体(AbCam, ab5690)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 3e). PLoS Pathog (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2d
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2d). Science (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 7
艾博抗(上海)贸易有限公司 CD3E抗体(abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 7). elife (2016) ncbi
小鼠 单克隆(PS1)
  • 免疫组化; 人类; 图 4
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, Ab699)被用于被用于免疫组化在人类样本上 (图 4). J Transl Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:100
艾博抗(上海)贸易有限公司 CD3E抗体(abcam, ab5690)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100. J Transl Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:100; 图 s1
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s1). Nat Neurosci (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 s4
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab5690)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4). Cancer Discov (2016) ncbi
小鼠 单克隆(PS1)
  • 免疫组化-石蜡切片; 人类; 1:5; 表 3
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, PS1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:5 (表 3). ORL J Otorhinolaryngol Relat Spec (2015) ncbi
小鼠 单克隆(PS1)
  • 免疫组化; 人类
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab699)被用于被用于免疫组化在人类样本上. J Invest Dermatol (2015) ncbi
小鼠 单克隆(PS1)
  • 免疫组化-石蜡切片; 人类; 1:50
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, ab699)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Br J Dermatol (2014) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫组化-石蜡切片; 小鼠; 1:100
艾博抗(上海)贸易有限公司 CD3E抗体(Abcam, Ab424)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100. Eur Respir J (2014) ncbi
伯乐(Bio-Rad)公司
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 1f
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA 1477)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 1f). Int J Mol Sci (2021) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 食蟹猴; 1:600; 图 s5e
伯乐(Bio-Rad)公司 CD3E抗体(BioRad, MCA1477)被用于被用于免疫组化在食蟹猴样本上浓度为1:600 (图 s5e). Cell (2021) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 图 s1
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, MCA1477)被用于被用于免疫组化在小鼠样本上 (图 s1). Front Physiol (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 3c
伯乐(Bio-Rad)公司 CD3E抗体(Sigma, MCA1477T)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3c). JACC Basic Transl Sci (2020) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 5b
伯乐(Bio-Rad)公司 CD3E抗体(Bio-Rad, MCA1477)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 5b). Nature (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 e8d
伯乐(Bio-Rad)公司 CD3E抗体(Bio-Rad, MCA1477T)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 e8d). Nature (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 1:300; 图 1a
  • 免疫组化-石蜡切片; 人类; 1:300; 图 1a
伯乐(Bio-Rad)公司 CD3E抗体(Biorad/Serotec, MCA1477)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:300 (图 1a) 和 被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (图 1a). JCI Insight (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 4b
伯乐(Bio-Rad)公司 CD3E抗体(Bio-Rad, MCA1477)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 4b). FASEB J (2019) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 图 1b
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, MC1477)被用于被用于免疫组化在小鼠样本上 (图 1b). J Exp Med (2018) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; 犬; 图 5
伯乐(Bio-Rad)公司 CD3E抗体(AbD serotec, MCA1477)被用于被用于流式细胞仪在犬样本上 (图 5). F1000Res (2015) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 1c
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 1c). Nat Commun (2017) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4
伯乐(Bio-Rad)公司 CD3E抗体(Bio-Rad, MCA1477T)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4). Sci Rep (2016) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; 小鼠; 1:200; 图 2
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 2). J Neuroinflammation (2016) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; 小鼠; 图 6e
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477)被用于被用于流式细胞仪在小鼠样本上 (图 6e). J Neuroinflammation (2016) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; pigs ; 1:100; 图 1
伯乐(Bio-Rad)公司 CD3E抗体(Biorad, MCA1477)被用于被用于免疫组化-石蜡切片在pigs 样本上浓度为1:100 (图 1). PLoS Negl Trop Dis (2016) ncbi
大鼠 单克隆(CD3-12)
  • 免疫细胞化学; 人类; 图 3
伯乐(Bio-Rad)公司 CD3E抗体(AbDSerotec, 1477)被用于被用于免疫细胞化学在人类样本上 (图 3). Sci Rep (2016) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 6
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, CD3-12)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6). Nat Immunol (2015) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠; 1:500; 图 4d
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, MCA1477)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 4d). J Immunother Cancer (2015) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 人类
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, CD3-12)被用于被用于免疫组化在人类样本上. Histochem Cell Biol (2015) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; 人类; 图 7
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1711C)被用于被用于流式细胞仪在人类样本上 (图 7). PLoS ONE (2015) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; domestic rabbit; 图 8
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, MCA1477)被用于被用于流式细胞仪在domestic rabbit样本上 (图 8). PLoS ONE (2015) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; African green monkey
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, CD3-12)被用于被用于免疫组化-石蜡切片在African green monkey样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化-冰冻切片; 人类; 1 ug/ml; 图 3a
伯乐(Bio-Rad)公司 CD3E抗体(AbDSerotec, UCHT1)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1 ug/ml (图 3a). J Clin Invest (2015) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠; 图 2
伯乐(Bio-Rad)公司 CD3E抗体(Serotic, CD3-12)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2). Am J Pathol (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 人类; 1:100
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, CD3-12)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. J Immunol (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 犬; 1:500
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477T)被用于被用于免疫组化在犬样本上浓度为1:500. PLoS ONE (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 人类; 1:100
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, MCA1477)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Ann Neurol (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 犬; 1:50
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477)被用于被用于免疫组化在犬样本上浓度为1:50. PLoS ONE (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化; 小鼠
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, MCA1477)被用于被用于免疫组化在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-石蜡切片; 小鼠
伯乐(Bio-Rad)公司 CD3E抗体(AbD Serotec, CD3-12)被用于被用于免疫组化-石蜡切片在小鼠样本上. Mucosal Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, Clone UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Transfusion (2014) ncbi
大鼠 单克隆(CD3-12)
  • 免疫组化-冰冻切片; 小鼠
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, CD3-12)被用于被用于免疫组化-冰冻切片在小鼠样本上. J Neuroinflammation (2013) ncbi
大鼠 单克隆(CD3-12)
  • 免疫细胞化学; 猫
伯乐(Bio-Rad)公司 CD3E抗体(Serotec, CD3-12)被用于被用于免疫细胞化学在猫样本上. Can Vet J (2011) ncbi
圣克鲁斯生物技术
小鼠 单克隆(PC3/188A)
  • 免疫组化; 小鼠; 1:1000; 图 5d
圣克鲁斯生物技术 CD3E抗体(Santa Cruz, sc20047)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 5d). Nat Commun (2021) ncbi
小鼠 单克隆(A-1)
  • 免疫印迹; 小鼠; 1:1000; 图 6c
圣克鲁斯生物技术 CD3E抗体(Santa, sc-137095)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6c). Nat Commun (2018) ncbi
小鼠 单克隆(UCH-T1)
  • 免疫组化-冰冻切片; 人类; 图 2d
圣克鲁斯生物技术 CD3E抗体(Santa Cruz, Sc-1179)被用于被用于免疫组化-冰冻切片在人类样本上 (图 2d). J Clin Invest (2017) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 人类; 1:200
圣克鲁斯生物技术 CD3E抗体(Santa Cruz, sc-20047)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Oncol Lett (2016) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 s8a
圣克鲁斯生物技术 CD3E抗体(SantaCruz, sc-20047)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 s8a). Nat Commun (2016) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 小鼠; 图 5a
圣克鲁斯生物技术 CD3E抗体(Santa Cruz, sc-20047)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5a). Int Immunopharmacol (2016) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
圣克鲁斯生物技术 CD3E抗体(santa Cruz, sc-20047)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1). Oncol Lett (2016) ncbi
小鼠 单克隆(PC3/188A)
  • 流式细胞仪; 大鼠; 1:1000
圣克鲁斯生物技术 CD3E抗体(Santa Cruz Biotechnology, sc-20047)被用于被用于流式细胞仪在大鼠样本上浓度为1:1000. Mol Med Rep (2015) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 小鼠; 图 6
圣克鲁斯生物技术 CD3E抗体(Santa Cruz Biotechnology, SC-20047)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6). J Biol Chem (2015) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化-石蜡切片; 小鼠; 图 6
圣克鲁斯生物技术 CD3E抗体(Santa, sc20047)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6). Br J Pharmacol (2014) ncbi
小鼠 单克隆(PC3/188A)
  • 免疫组化; 小鼠
圣克鲁斯生物技术 CD3E抗体(Santa Cruz, sc-20047)被用于被用于免疫组化在小鼠样本上. Kidney Int (2013) ncbi
美天旎
人类 单克隆(REA613)
  • 流式细胞仪; 人类; 1:100; 图 2f
美天旎 CD3E抗体(Miltenyi, 130-113-138)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2f). Nat Med (2021) ncbi
人类 单克隆(REA613)
  • 流式细胞仪; 小鼠; 图 s2a
美天旎 CD3E抗体(Miltenyi Biotec, 130-113-141)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). Cell (2020) ncbi
人类 单克隆(REA613)
  • 流式细胞仪; 人类; 图 1a
美天旎 CD3E抗体(Miltenyi Biotec, REA613)被用于被用于流式细胞仪在人类样本上 (图 1a). JCI Insight (2017) ncbi
西格玛奥德里奇
domestic rabbit 单克隆(SP162)
  • 免疫组化-石蜡切片; 猕猴; 图 7a
西格玛奥德里奇 CD3E抗体(Sigma, SAB5500057)被用于被用于免疫组化-石蜡切片在猕猴样本上 (图 7a). Cell (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 犬; 图 42
西格玛奥德里奇 CD3E抗体(Sigma-aldrich, C7930)被用于被用于免疫组化在犬样本上 (图 42). J Toxicol Pathol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 s5a
西格玛奥德里奇 CD3E抗体(Sigma, C7930)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s5a). PLoS ONE (2016) ncbi
Novus Biologicals
domestic rabbit 单克隆(SP7)
  • 免疫组化; 人类; 1:100; 图 4d
Novus Biologicals CD3E抗体(Novus, SP7)被用于被用于免疫组化在人类样本上浓度为1:100 (图 4d). Acta Neuropathol (2021) ncbi
domestic rabbit 单克隆(SP7)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 1e
Novus Biologicals CD3E抗体(Novus Biological, SP7)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 1e). Nature (2019) ncbi
Bio X Cell
小鼠 单克隆(UCHT1 (Leu-4)(T3))
  • 流式细胞仪; 人类; 表 1
Bio X Cell CD3E抗体(BioXCell, UCHT1)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(OKT-3)
  • 抑制或激活实验; 人类; 图 3
Bio X Cell CD3E抗体(BioXCell, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 3). Eur J Immunol (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D4V8L)
  • 免疫组化; 小鼠; 1:200; 图 2c, 2f
赛信通(上海)生物试剂有限公司 CD3E抗体(Cell Signaling, 99940)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 2c, 2f). J Immunother Cancer (2021) ncbi
domestic rabbit 单克隆(D4V8L)
  • 免疫组化; 小鼠; 图 3e
赛信通(上海)生物试剂有限公司 CD3E抗体(Cell Signaling Technology, D4V8L)被用于被用于免疫组化在小鼠样本上 (图 3e). Nat Commun (2020) ncbi
大鼠 单克隆(CD3-12)
  • 流式细胞仪; 人类; 1:1000; 表 1
赛信通(上海)生物试剂有限公司 CD3E抗体(Cell signaling, 4443)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (表 1). Exp Ther Med (2016) ncbi
National Institutes of Health AIDS Research and Reference Reagent Program
unidentified 重组(12277)
  • 流式细胞仪; 人类; 图 s1a
National Institutes of Health AIDS Research and Reference Reagent Program CD3E抗体(NHP试剂, PR-3802)被用于被用于流式细胞仪在人类样本上 (图 s1a). Cell (2019) ncbi
Fitzgerald Industries
  • 免疫细胞化学; 人类; 1:250
  • 免疫印迹; 人类; 1:500; 图 2
Fitzgerald Industries CD3E抗体(Fitzgerald, 10C-CR8008M1)被用于被用于免疫细胞化学在人类样本上浓度为1:250 和 被用于免疫印迹在人类样本上浓度为1:500 (图 2). Int J Oncol (2014) ncbi
Exbio
小鼠 单克隆(MEM-57)
  • 流式细胞仪; 人类; 图 2
Exbio CD3E抗体(Exbio, A7-202-T100)被用于被用于流式细胞仪在人类样本上 (图 2). Oncoimmunology (2015) ncbi
Tonbo Biosciences
单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1a
Tonbo Biosciences CD3E抗体(Tonbo Biosciences, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1a). Oncotarget (2017) ncbi
碧迪BD
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:300; 图 6a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:300 (图 6a). Nat Commun (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3c, 3d
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3c, 3d). J Immunother Cancer (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, 555341)被用于被用于流式细胞仪在人类样本上. Cell (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). Int J Mol Sci (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1b). Acta Neuropathol (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:500
碧迪BD CD3E抗体(BD, 555332)被用于被用于流式细胞仪在人类样本上浓度为1:500. Cell (2021) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:200; 图 s1h
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1h). Nature (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). Aging Cell (2021) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:50; 图 3s2a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 3s2a). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3a). BMC Cancer (2020) ncbi
小鼠 单克隆(UCHT1)
  • 其他; 小鼠
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于其他在小鼠样本上. Nat Commun (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD Biosciences, 552851/339186)被用于被用于流式细胞仪在人类样本上 (图 3a). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 1f
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1f). elife (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1a). Rheumatology (Oxford) (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). J Extracell Vesicles (2020) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 1d
碧迪BD CD3E抗体(BD Biosciences, 550368)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 1d). elife (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1a). Sci Adv (2020) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 小鼠; 图 s2a
  • 流式细胞仪; 人类; 图 s2a
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在小鼠样本上 (图 s2a) 和 被用于流式细胞仪在人类样本上 (图 s2a). Nature (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD3E抗体(BD Bioscience, 560365)被用于被用于流式细胞仪在人类样本上 (图 5c). Stem Cell Res Ther (2020) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD, 347347)被用于被用于流式细胞仪在人类样本上 (图 1). J Cancer (2020) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3a). Science (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:50; 图 4c
碧迪BD CD3E抗体(BD, 557851)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 4c). Nature (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:200; 图 1s1a
碧迪BD CD3E抗体(BD Pharmagen, 340440)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1s1a). elife (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:1000; 图 4d
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 4d). PLoS Pathog (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 3). Sci Rep (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:20; 图 5k, s22c
碧迪BD CD3E抗体(BD Biosciences, 561416)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 5k, s22c). Nat Commun (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). JCI Insight (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:200; 图 2s1b
碧迪BD CD3E抗体(BD, 555339)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2s1b). elife (2019) ncbi
小鼠 单克隆(SK7)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 s3a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 s3a). J Invest Dermatol (2019) ncbi
小鼠 单克隆(UCHT1)
  • mass cytometry; 人类; 图 s1
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于mass cytometry在人类样本上 (图 s1). J Exp Med (2019) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 1-10 ug/ml; 图 s2g
碧迪BD CD3E抗体(BD, 555336)被用于被用于抑制或激活实验在人类样本上浓度为1-10 ug/ml (图 s2g). J Exp Med (2019) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化-冰冻切片; 人类; 图 1b
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1b). J Clin Invest (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Eur J Immunol (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Immunol Cell Biol (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2019) ncbi
小鼠 单克隆(HIT3a)
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于. Am J Transplant (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Virol (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s5b, s5c
碧迪BD CD3E抗体(BD, 339186)被用于被用于流式细胞仪在人类样本上 (图 s5b, s5c). Cell (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). Cancer (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s3). J Infect Dis (2019) ncbi
小鼠 单克隆(SK7)
  • 免疫组化; 人类; 1:100; 图 3a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于免疫组化在人类样本上浓度为1:100 (图 3a). Ann Allergy Asthma Immunol (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1c). Int J Hematol (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s7c
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s7c). Leukemia (2019) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 5 ug/ml; 图 1b
碧迪BD CD3E抗体(BD Pharmingen, HIT3a)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml (图 1b). J Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s7b
碧迪BD CD3E抗体(BD, 555916)被用于被用于流式细胞仪在人类样本上 (图 s7b). Eur J Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6h, 6i
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 6h, 6i). Cancer Res (2018) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化-冰冻切片; 人类; 图 2a
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 2a) 和 被用于流式细胞仪在人类样本上 (图 1b). J Exp Med (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Biosciences, 557851)被用于被用于流式细胞仪在人类样本上 (图 2a). J Virol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, 555916)被用于被用于流式细胞仪在人类样本上 (图 1). Oncotarget (2018) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 小鼠; 图 s13
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在小鼠样本上 (图 s13). J Clin Invest (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 14
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 14). Front Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD3E抗体(BD, 555332)被用于被用于流式细胞仪在人类样本上 (图 1e). J Exp Med (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3e
碧迪BD CD3E抗体(BD Biosciences, 561806)被用于被用于流式细胞仪在人类样本上 (图 3e). Cell (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 5a). Obes Facts (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 2b). Nat Med (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 3a). J Virol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Biosciences, UCHT - 1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s4a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Immunol (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s2e
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2e). Nature (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s8e
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s8e). Nature (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD Pharmingen, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncoimmunology (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Med (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 st12
碧迪BD CD3E抗体(BD, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD3E抗体(BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1d). J Clin Invest (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s6d
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s6d). Science (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5a). Cancer Res (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6b
碧迪BD CD3E抗体(BD Biosciences, 561807)被用于被用于流式细胞仪在人类样本上 (图 6b). Mol Ther Methods Clin Dev (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD3E抗体(BD, UCHT-1)被用于被用于流式细胞仪在人类样本上 (表 2). J Immunol Methods (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). Nature (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2017) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 图 2e
碧迪BD CD3E抗体(BD, 555329)被用于被用于抑制或激活实验在人类样本上 (图 2e). Sci Rep (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 S1a
碧迪BD CD3E抗体(BD, 561807)被用于被用于流式细胞仪在人类样本上 (图 S1a). Sci Rep (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD3E抗体(BD, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 3d). Oncoimmunology (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5). Genome Med (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1). Haematologica (2017) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 图 2d
碧迪BD CD3E抗体(BD Bioscience, HIT3a)被用于被用于抑制或激活实验在人类样本上 (图 2d). Clin Exp Allergy (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol Res (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1c
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1c). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:100; 图 2a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2a). J Leukoc Biol (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s12c
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 s12c). J Clin Invest (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Virol (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD3E抗体(BD Pharmingen, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1c). J Autoimmun (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:20; 图 1c
碧迪BD CD3E抗体(BD Biosciences, 555332)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1c). Nat Commun (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5b
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 5b). JCI Insight (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD3E抗体(BD Biosciences, UCHTI)被用于被用于流式细胞仪在人类样本上 (图 6). New Microbiol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a, 1e
碧迪BD CD3E抗体(BD Biosciences, 557851)被用于被用于流式细胞仪在人类样本上 (图 1a, 1e). JCI Insight (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5a). J Exp Med (2016) ncbi
小鼠 单克隆(HIT3a)
  • 免疫组化-冰冻切片; 人类; 图 7b
碧迪BD CD3E抗体(BD Biosciences, HIT3A)被用于被用于免疫组化-冰冻切片在人类样本上 (图 7b). Cancer Res (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD3E抗体(BD Biosciences, 557832)被用于被用于流式细胞仪在人类样本上 (图 3c). Nanomedicine (Lond) (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Interferon Cytokine Res (2016) ncbi
小鼠 单克隆(SK7)
  • 免疫组化; 人类; 图 2a
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于免疫组化在人类样本上 (图 2a). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1a). Sci Rep (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 st9
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s2b
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2b). Oncotarget (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Biomaterials (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2e
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2e). J Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1e). J Allergy Clin Immunol (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD Pharmingen, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 3a). Clin Cancer Res (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1d). Clin Transl Gastroenterol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). J Clin Invest (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s3a). J Clin Invest (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3b
  • 流式细胞仪; 小鼠; 图 st1
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3b) 和 被用于流式细胞仪在小鼠样本上 (图 st1). J Clin Invest (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5e
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5e). J Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s5b
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s5b). Nat Commun (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:50; 图 1d
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1d). Nat Med (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3d). J Leukoc Biol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:50; 图 1e
碧迪BD CD3E抗体(BD, 557851)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1e). Nat Cell Biol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:100; 图 1
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS ONE (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:40; 图 3
碧迪BD CD3E抗体(BD PharMingen, 560365)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:50; 图 2
碧迪BD CD3E抗体(BD PharMingen, 347347)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 图 4
碧迪BD CD3E抗体(BD Pharmigen, 555336)被用于被用于抑制或激活实验在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). Ann Clin Transl Neurol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Crohns Colitis (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Crohns Colitis (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. J Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD3E抗体(BD Bioscience, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS ONE (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2b). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 7.45.3
碧迪BD CD3E抗体(BD Biosciences, 340661)被用于被用于流式细胞仪在人类样本上 (图 7.45.3). Curr Protoc Cytom (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1b). J Virol (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2016) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 2e
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 2e). Nat Genet (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 小鼠; 图 1c
碧迪BD CD3E抗体(BD Biosciences, 555329)被用于被用于抑制或激活实验在小鼠样本上 (图 1c). Nat Commun (2015) ncbi
小鼠 单克隆(HIT3a)
  • 免疫印迹; 人类; 2.5 ug/ml; 图 1
碧迪BD CD3E抗体(BD Biosciences, 555336)被用于被用于免疫印迹在人类样本上浓度为2.5 ug/ml (图 1). Free Radic Biol Med (2015) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 2.5 ug/ml; 图 1
  • 免疫印迹; 人类; 2.5 ug/ml; 图 1
碧迪BD CD3E抗体(BD Biosciences, 555336)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml (图 1) 和 被用于免疫印迹在人类样本上浓度为2.5 ug/ml (图 1). Genes Dev (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD3E抗体(BD Biosciences, 555338)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD3E抗体(BD PharMingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3a). Hum Vaccin Immunother (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS Negl Trop Dis (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, 555332)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. Biol Blood Marrow Transplant (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 4
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4). PLoS ONE (2015) ncbi
小鼠 单克隆(SK7)
  • 免疫组化; 人类; 表 s4
碧迪BD CD3E抗体(BD Biosciences, 347340)被用于被用于免疫组化在人类样本上 (表 s4). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 猕猴
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在猕猴样本上. Vaccine (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Bioscience, 557832)被用于被用于流式细胞仪在人类样本上 (图 1). J Hematol Oncol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Ann Rheum Dis (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, 560366)被用于被用于流式细胞仪在人类样本上. J Exp Med (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类
碧迪BD CD3E抗体(BD Pharmingen, 555329)被用于被用于抑制或激活实验在人类样本上. J Immunol Methods (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 2). Nat Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 S1
碧迪BD CD3E抗体(BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 S1). Retrovirology (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上 (图 6). Bone Marrow Transplant (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 4
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(HIT3a)
  • 其他; 人类; 图 2
碧迪BD CD3E抗体(BD Biosciences, 555337)被用于被用于其他在人类样本上 (图 2). J Extracell Vesicles (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 2:100; 图 3a
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上浓度为2:100 (图 3a). Nat Commun (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 5 ul/test
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上浓度为5 ul/test. J Immunol Methods (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
  • 流式细胞仪; 食蟹猴
碧迪BD CD3E抗体(BD, 340440)被用于被用于流式细胞仪在人类样本上 和 被用于流式细胞仪在食蟹猴样本上. MAbs (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS Med (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, 555338)被用于被用于流式细胞仪在人类样本上. Nat Commun (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, 555338)被用于被用于流式细胞仪在人类样本上. Nat Commun (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 2). Clin Transplant (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD3E抗体(BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 2). J Virol (2015) ncbi
小鼠 单克隆(SK7)
  • 抑制或激活实验; 人类; 图 s3
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于抑制或激活实验在人类样本上 (图 s3). Diabetes (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Pharmingen, clone SK7)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, 555338)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 1). J Leukoc Biol (2015) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD3E抗体(BD, Hit3a)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Nat Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Nat Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 2
碧迪BD CD3E抗体(BD Pharmingen, 555329)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 2). Mol Cell Biol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠; 图 s3
碧迪BD CD3E抗体(Pharmingen, 555332)被用于被用于流式细胞仪在小鼠样本上 (图 s3). Stem Cell Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. J Hepatol (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 10 ul per test
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为10 ul per test. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, SK7)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. Inflamm Bowel Dis (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, Clone SK7)被用于被用于流式细胞仪在人类样本上. Vaccine (2014) ncbi
小鼠 单克隆(UCHT1)
  • 免疫细胞化学; 小鼠
碧迪BD CD3E抗体(PharMingen, UCHT1)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD3E抗体(BD, 550367)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Atherosclerosis (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Horizon, UCHT1)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2014) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 1:100
碧迪BD CD3E抗体(BD Biosciences, 555339)被用于被用于流式细胞仪在人类样本上浓度为1:100. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:20
碧迪BD CD3E抗体(BD Biosciences, 560365)被用于被用于流式细胞仪在人类样本上浓度为1:20. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 1:40
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:40. Nat Commun (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1.6:100
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1.6:100. J Clin Invest (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2014) ncbi
小鼠 单克隆(SK7)
  • 免疫组化; 人类
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于免疫组化在人类样本上. Arthritis Rheumatol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; African green monkey; 图 1a
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在African green monkey样本上 (图 1a). Cell Immunol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 大鼠
碧迪BD CD3E抗体(BD, 557832)被用于被用于流式细胞仪在大鼠样本上. J Immunol (2014) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 10 ug/ml
碧迪BD CD3E抗体(BD, 555336)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml. PLoS ONE (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD3E抗体(BD Bio-sciences, clone SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Environ Toxicol Pharmacol (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD3E抗体(Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, 555332)被用于被用于流式细胞仪在人类样本上. Nat Med (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD/Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD3E抗体(BD, clone SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Retrovirology (2013) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
碧迪BD CD3E抗体(BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD3E抗体(BD, 641406)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD3E抗体(BD Pharmingen, 555332)被用于被用于流式细胞仪在人类样本上 (图 5). Cell Transplant (2014) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化-冰冻切片; 人类; 0.25 ug/ml
碧迪BD CD3E抗体(BD Pharmingen, 555330)被用于被用于免疫组化-冰冻切片在人类样本上浓度为0.25 ug/ml. Neuropathol Appl Neurobiol (2014) ncbi
小鼠 单克隆(SK7)
  • 免疫组化; 人类
碧迪BD CD3E抗体(BD, SK7)被用于被用于免疫组化在人类样本上. Blood (2008) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD CD3E抗体(BD Biosciences, HIT3a)被用于被用于流式细胞仪在小鼠样本上 (图 3). Blood (2007) ncbi
Nanotools
小鼠 单克隆(4D7)
  • 免疫印迹; 人类; 1:200; 图 st1
Nanotools CD3E抗体(Nanotools, 0172-100)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
ATCC
小鼠 单克隆
  • 流式细胞仪; 人类; 1 ug/ml; 图 1
ATCC CD3E抗体(ATCC, CRL-8001)被用于被用于流式细胞仪在人类样本上浓度为1 ug/ml (图 1). Oncoimmunology (2016) ncbi
徕卡显微系统(上海)贸易有限公司
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:60; 图 2c
徕卡显微系统(上海)贸易有限公司 CD3E抗体(Novocastra, CD3-PS1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:60 (图 2c). Mod Pathol (2015) ncbi
文章列表
  1. Ni Y, Hu B, Wu G, Shao Z, Zheng Y, Zhang R, et al. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11:9431-9451 pubmed 出版商
  2. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed 出版商
  3. Ming S, Yin H, Li X, Gong S, Zhang G, Wu Y. GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis. Front Immunol. 2021;12:736269 pubmed 出版商
  4. Wright J, Bazile C, Clark E, Carlesso G, Boucher J, Kleiman E, et al. Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk. Front Immunol. 2021;12:705307 pubmed 出版商
  5. Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C, et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22: pubmed 出版商
  6. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed 出版商
  7. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed 出版商
  8. Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021;12:4821 pubmed 出版商
  9. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed 出版商
  10. Guo D, Yamamoto M, Hernandez C, Khodadadi H, Baban B, Stranahan A. Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice. Nat Commun. 2021;12:4623 pubmed 出版商
  11. Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed 出版商
  12. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed 出版商
  13. Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, et al. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci Rep. 2021;11:15075 pubmed 出版商
  14. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed 出版商
  15. Goyette M, Elkholi I, Apcher C, Kuasne H, Rothlin C, Muller W, et al. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A. 2021;118: pubmed 出版商
  16. Nathan A, Rossin E, Kaseke C, Park R, Khatri A, Koundakjian D, et al. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell. 2021;: pubmed 出版商
  17. Hajihosseini A, Hutcherson C. Alpha oscillations and event-related potentials reflect distinct dynamics of attribute construction and evidence accumulation in dietary decision making. elife. 2021;10: pubmed 出版商
  18. Niu G, Cui Y, Wang X, Keleta Y, Li J. Studies of the Parasite-Midgut Interaction Reveal Plasmodium Proteins Important for Malaria Transmission to Mosquitoes. Front Cell Infect Microbiol. 2021;11:654216 pubmed 出版商
  19. Kwon D. This 'super antibody' for COVID fights off multiple coronaviruses. Nature. 2021;: pubmed 出版商
  20. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed 出版商
  21. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed 出版商
  22. Altvater B, Kailayangiri S, Pérez Lanuza L, Urban K, Greune L, Flügge M, et al. HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells. Cancers (Basel). 2021;13: pubmed 出版商
  23. Amanat F, Thapa M, Lei T, Ahmed S, Adelsberg D, Carreño J, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021;184:3936-3948.e10 pubmed 出版商
  24. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed 出版商
  25. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed 出版商
  26. He X, Chandrashekar A, Zahn R, Wegmann F, Yu J, Mercado N, et al. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021;184:3467-3473.e11 pubmed 出版商
  27. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed 出版商
  28. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed 出版商
  29. Zheng J, MEYERHOLZ D, Wong L, Gelb M, Murakami M, Perlman S. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D. J Clin Invest. 2021;131: pubmed 出版商
  30. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed 出版商
  31. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed 出版商
  32. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed 出版商
  33. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed 出版商
  34. Egedal J, Xie G, Packard T, Laustsen A, Neidleman J, Georgiou K, et al. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunol. 2021;: pubmed 出版商
  35. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed 出版商
  36. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed 出版商
  37. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed 出版商
  38. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed 出版商
  39. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed 出版商
  40. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed 出版商
  41. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed 出版商
  42. Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed 出版商
  43. Vemulapalli V, Chylek L, Erickson A, Pfeiffer A, Gabriel K, LaRochelle J, et al. Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling. elife. 2021;10: pubmed 出版商
  44. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed 出版商
  45. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021;184:1821-1835.e16 pubmed 出版商
  46. Hsiue E, Wright K, Douglass J, Hwang M, Mog B, Pearlman A, et al. Targeting a neoantigen derived from a common TP53 mutation. Science. 2021;371: pubmed 出版商
  47. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed 出版商
  48. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed 出版商
  49. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed 出版商
  50. Greferath U, Huynh M, Jobling A, Vessey K, Venables G, Surrao D, et al. Dorsal-Ventral Differences in Retinal Structure in the Pigmented Royal College of Surgeons Model of Retinal Degeneration. Front Cell Neurosci. 2020;14:553708 pubmed 出版商
  51. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed 出版商
  52. Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644 pubmed 出版商
  53. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed 出版商
  54. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed 出版商
  55. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed 出版商
  56. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed 出版商
  57. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed 出版商
  58. Abbate J, Macri F, Capparucci F, Iaria C, Briguglio G, Cicero L, et al. Administration of Protein Hydrolysates from Anchovy (Engraulis Encrasicolus) Waste for Twelve Weeks Decreases Metabolic Dysfunction-Associated Fatty Liver Disease Severity in ApoE-/-Mice. Animals (Basel). 2020;10: pubmed 出版商
  59. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed 出版商
  60. Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. elife. 2020;9: pubmed 出版商
  61. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed 出版商
  62. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed 出版商
  63. Wang C, Weng M, Xia S, Zhang M, Chen C, Tang J, et al. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Cancer Sci. 2021;112:178-193 pubmed 出版商
  64. Moreno Valladares M, Silva T, Garcés J, Sáenz Antoñanzas A, Moreno Cugnon L, Álvarez Satta M, et al. CD8+ T cells are present at low levels in the white matter with physiological and pathological aging. Aging (Albany NY). 2020;12:18928-18941 pubmed 出版商
  65. Deeba E, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. BMC Res Notes. 2020;13:460 pubmed 出版商
  66. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed 出版商
  67. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed 出版商
  68. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89-94 pubmed 出版商
  69. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed 出版商
  70. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed 出版商
  71. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed 出版商
  72. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed 出版商
  73. Kim J, Lee J, Go H, Lim J, Oh J, Kim Y, et al. Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis. Arthritis Res Ther. 2020;22:173 pubmed 出版商
  74. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed 出版商
  75. Asare Y, Koehncke J, Selle J, Simsekyilmaz S, Jankowski J, Shagdarsuren G, et al. Differential Role for Activating FcγRIII in Neointima Formation After Arterial Injury and Diet-Induced Chronic Atherosclerosis in Apolipoprotein E-Deficient Mice. Front Physiol. 2020;11:673 pubmed 出版商
  76. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed 出版商
  77. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed 出版商
  78. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed 出版商
  79. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed 出版商
  80. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed 出版商
  81. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed 出版商
  82. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed 出版商
  83. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed 出版商
  84. Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed 出版商
  85. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed 出版商
  86. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed 出版商
  87. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed 出版商
  88. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed 出版商
  89. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed 出版商
  90. Lubow J, Virgilio M, Merlino M, Collins D, Mashiba M, Peterson B, et al. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. elife. 2020;9: pubmed 出版商
  91. Yazawa K, Nakamura F, Masukawa D, Sato S, Hiroshima Y, Yabushita Y, et al. Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancreatic Cancer. Transl Oncol. 2020;13:100746 pubmed 出版商
  92. Minervina A, Pogorelyy M, Komech E, Karnaukhov V, Bacher P, Rosati E, et al. Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones. elife. 2020;9: pubmed 出版商
  93. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed 出版商
  94. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed 出版商
  95. Yiu G, Chung S, Mollhoff I, Nguyen U, Thomasy S, Yoo J, et al. Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates. Mol Ther Methods Clin Dev. 2020;16:179-191 pubmed 出版商
  96. Guo X, Kolpakov M, Hooshdaran B, Schappell W, Wang T, Eguchi S, et al. Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload. JACC Basic Transl Sci. 2020;5:69-83 pubmed 出版商
  97. Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020;578:160-165 pubmed 出版商
  98. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed 出版商
  99. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed 出版商
  100. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed 出版商
  101. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed 出版商
  102. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed 出版商
  103. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed 出版商
  104. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed 出版商
  105. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed 出版商
  106. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed 出版商
  107. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed 出版商
  108. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed 出版商
  109. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed 出版商
  110. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed 出版商
  111. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed 出版商
  112. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed 出版商
  113. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed 出版商
  114. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed 出版商
  115. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed 出版商
  116. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed 出版商
  117. Götzke H, Kilisch M, Martínez Carranza M, Sograte Idrissi S, Rajavel A, Schlichthaerle T, et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun. 2019;10:4403 pubmed 出版商
  118. Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430-433 pubmed 出版商
  119. Fu D, Senouthai S, Wang J, You Y. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance. BMC Nephrol. 2019;20:350 pubmed 出版商
  120. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed 出版商
  121. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed 出版商
  122. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed 出版商
  123. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed 出版商
  124. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed 出版商
  125. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed 出版商
  126. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed 出版商
  127. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed 出版商
  128. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  129. Brook A, Jenkins R, Clayton A, Kift Morgan A, Raby A, Shephard A, et al. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis. Sci Rep. 2019;9:10136 pubmed 出版商
  130. Gehrig J, Venkatesh S, Chang H, Hibberd M, Kung V, Cheng J, et al. Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science. 2019;365: pubmed 出版商
  131. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed 出版商
  132. Dulken B, Buckley M, Navarro Negredo P, Saligrama N, Cayrol R, Leeman D, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205-210 pubmed 出版商
  133. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed 出版商
  134. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed 出版商
  135. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed 出版商
  136. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed 出版商
  137. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed 出版商
  138. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed 出版商
  139. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed 出版商
  140. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed 出版商
  141. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed 出版商
  142. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed 出版商
  143. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed 出版商
  144. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  145. Garcia Agudo L, Janova H, Sendler L, Arinrad S, Steixner A, Hassouna I, et al. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion. FASEB J. 2019;33:8634-8647 pubmed 出版商
  146. Cirelli K, Carnathan D, Nogal B, Martin J, Rodriguez O, Upadhyay A, et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance. Cell. 2019;177:1153-1171.e28 pubmed 出版商
  147. Del Duca E, Pavel A, Dubin C, Song T, Wallace E, Peng X, et al. Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals. J Invest Dermatol. 2019;139:2228-2232.e10 pubmed 出版商
  148. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed 出版商
  149. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed 出版商
  150. Walens A, DiMarco A, Lupo R, Kroger B, Damrauer J, Alvarez J. CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. elife. 2019;8: pubmed 出版商
  151. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  152. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed 出版商
  153. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed 出版商
  154. Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M, et al. IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019;129:1926-1939 pubmed 出版商
  155. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed 出版商
  156. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  157. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed 出版商
  158. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed 出版商
  159. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed 出版商
  160. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed 出版商
  161. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed 出版商
  162. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed 出版商
  163. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed 出版商
  164. Franco L, Gadkari M, Howe K, Sun J, Kardava L, Kumar P, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med. 2019;216:384-406 pubmed 出版商
  165. Taura M, Song E, Ho Y, Iwasaki A. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat. Proc Natl Acad Sci U S A. 2019;116:2282-2289 pubmed 出版商
  166. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed 出版商
  167. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed 出版商
  168. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed 出版商
  169. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed 出版商
  170. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed 出版商
  171. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed 出版商
  172. Tan H, Jegaskanda S, Juno J, Esterbauer R, Wong J, Kelly H, et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019;129:850-862 pubmed 出版商
  173. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed 出版商
  174. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed 出版商
  175. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed 出版商
  176. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed 出版商
  177. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed 出版商
  178. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed 出版商
  179. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed 出版商
  180. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed 出版商
  181. Cai Y, Abdel Mohsen M, Tomescu C, Xue F, Wu G, Howell B, et al. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation. J Virol. 2019;93: pubmed 出版商
  182. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed 出版商
  183. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed 出版商
  184. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed 出版商
  185. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed 出版商
  186. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed 出版商
  187. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed 出版商
  188. Sanyal R, Pavel A, Glickman J, Chan T, Zheng X, Zhang N, et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol. 2019;122:99-110.e6 pubmed 出版商
  189. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed 出版商
  190. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed 出版商
  191. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  192. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed 出版商
  193. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed 出版商
  194. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  195. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed 出版商
  196. Fischer M, Bantug G, Dimeloe S, Gubser P, Burgener A, Grählert J, et al. Early effector maturation of naïve human CD8+ T cells requires mitochondrial biogenesis. Eur J Immunol. 2018;48:1632-1643 pubmed 出版商
  197. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed 出版商
  198. Desimio M, Giuliani E, Ferraro A, Adorno G, Doria M. In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus. Front Immunol. 2018;9:1514 pubmed 出版商
  199. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed 出版商
  200. Zhao Y, Harrison D, Song Y, Ji J, Huang J, Hui E. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Cell Rep. 2018;24:379-390.e6 pubmed 出版商
  201. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed 出版商
  202. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed 出版商
  203. Pulikkan J, Hegde M, Ahmad H, Belaghzal H, Illendula A, Yu J, et al. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172-186.e21 pubmed 出版商
  204. Yang C, Chiu L, Chang C, Chuang H, Tan T. Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation. FASEB J. 2018;:fj201800244RR pubmed 出版商
  205. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed 出版商
  206. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed 出版商
  207. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed 出版商
  208. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed 出版商
  209. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed 出版商
  210. Maston L, Jones D, Giermakowska W, Resta T, Ramiro Diaz J, Howard T, et al. Interleukin-6 trans-signaling contributes to chronic hypoxia-induced pulmonary hypertension. Pulm Circ. 2018;8:2045894018780734 pubmed 出版商
  211. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed 出版商
  212. Kiani Z, Dupuy F, Bruneau J, Lebouché B, Zhang C, Jackson E, et al. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1. J Immunol. 2018;201:113-123 pubmed 出版商
  213. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed 出版商
  214. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed 出版商
  215. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed 出版商
  216. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed 出版商
  217. Foerster F, Boegel S, Heck R, Pickert G, R ssel N, Rosigkeit S, et al. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells. Oncoimmunology. 2018;7:e1409929 pubmed 出版商
  218. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed 出版商
  219. Flores Villanueva P, Ganachari M, Guio H, Mejia J, Granados J. An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines. J Immunol. 2018;200:2965-2977 pubmed 出版商
  220. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed 出版商
  221. Messlinger H, Sebald H, Heger L, Dudziak D, Bogdan C, Schleicher U. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites. Front Immunol. 2018;9:24 pubmed 出版商
  222. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed 出版商
  223. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed 出版商
  224. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed 出版商
  225. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed 出版商
  226. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed 出版商
  227. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed 出版商
  228. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed 出版商
  229. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed 出版商
  230. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed 出版商
  231. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed 出版商
  232. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed 出版商
  233. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed 出版商
  234. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed 出版商
  235. Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557 pubmed 出版商
  236. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed 出版商
  237. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed 出版商
  238. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed 出版商
  239. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  240. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed 出版商
  241. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed 出版商
  242. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed 出版商
  243. Jackson E, Zhang C, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 2017;12:e0185160 pubmed 出版商
  244. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  245. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  246. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed 出版商
  247. Kruglova N, Meshkova T, Kopylov A, Mazurov D, Filatov A. Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP). PLoS ONE. 2017;12:e0182468 pubmed 出版商
  248. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed 出版商
  249. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed 出版商
  250. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed 出版商
  251. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  252. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed 出版商
  253. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed 出版商
  254. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed 出版商
  255. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed 出版商
  256. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed 出版商
  257. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  258. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed 出版商
  259. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed 出版商
  260. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed 出版商
  261. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  262. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  263. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed 出版商
  264. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed 出版商
  265. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed 出版商
  266. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed 出版商
  267. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed 出版商
  268. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed 出版商
  269. Ito D, Childress M, Mason N, Winter A, O BRIEN T, Henson M, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res. 2015;4:42 pubmed 出版商
  270. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed 出版商
  271. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed 出版商
  272. Bittner S, Knoll G, Ehrenschwender M. Death receptor 3 signaling enhances proliferation of human regulatory T cells. FEBS Lett. 2017;591:1187-1195 pubmed 出版商
  273. Khodadoust M, Olsson N, Wagar L, Haabeth O, Chen B, Swaminathan K, et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. 2017;543:723-727 pubmed 出版商
  274. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed 出版商
  275. VALLABHAJOSYULA P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan C, et al. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017;127:1375-1391 pubmed 出版商
  276. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed 出版商
  277. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed 出版商
  278. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed 出版商
  279. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed 出版商
  280. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed 出版商
  281. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed 出版商
  282. Perander M, Al Mahdi R, Jensen T, Nunn J, Kildalsen H, Johansen B, et al. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2. Sci Rep. 2017;7:43471 pubmed 出版商
  283. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed 出版商
  284. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed 出版商
  285. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed 出版商
  286. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  287. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed 出版商
  288. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed 出版商
  289. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed 出版商
  290. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed 出版商
  291. Daniels B, Jujjavarapu H, Durrant D, Williams J, Green R, White J, et al. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest. 2017;127:843-856 pubmed 出版商
  292. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed 出版商
  293. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  294. Yamaguchi T, Sato H, Kato Itoh M, Goto T, Hara H, Sanbo M, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191-196 pubmed 出版商
  295. Berghoff S, Gerndt N, Winchenbach J, Stumpf S, Hosang L, Odoardi F, et al. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun. 2017;8:14241 pubmed 出版商
  296. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed 出版商
  297. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed 出版商
  298. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed 出版商
  299. Halbrook C, Wen H, Ruggeri J, Takeuchi K, Zhang Y, di Magliano M, et al. Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cell Mol Gastroenterol Hepatol. 2017;3:99-118 pubmed 出版商
  300. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  301. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  302. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed 出版商
  303. Larabee C, Desai S, Agasing A, Georgescu C, Wren J, Axtell R, et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016;22:1503-1513 pubmed
  304. Zhang Y, Yu J, Grachtchouk V, Qin T, Lumeng C, Sartor M, et al. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer. Oncotarget. 2017;8:5761-5773 pubmed 出版商
  305. Raap U, Gehring M, Kleiner S, Rüdrich U, Eiz Vesper B, Haas H, et al. Human basophils are a source of - and are differentially activated by - IL-31. Clin Exp Allergy. 2017;47:499-508 pubmed 出版商
  306. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  307. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  308. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  309. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  310. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed 出版商
  311. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed 出版商
  312. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  313. Villanueva Cabello T, Martinez Duncker I. Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy. J Vis Exp. 2016;: pubmed 出版商
  314. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed 出版商
  315. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed 出版商
  316. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed 出版商
  317. Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, et al. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017;91: pubmed 出版商
  318. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed 出版商
  319. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  320. Weingartner E, Courneya J, Keegan A, Golding A. A novel method for assaying human regulatory T cell direct suppression of B cell effector function. J Immunol Methods. 2017;441:1-7 pubmed 出版商
  321. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed 出版商
  322. Habiel D, Krepostman N, Lilly M, Cavassani K, Coelho A, Shibata T, et al. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma. Oncotarget. 2016;7:83514-83529 pubmed 出版商
  323. Gil V, Bhagat G, Howell L, Zhang J, Kim C, Stengel S, et al. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice. Dis Model Mech. 2016;9:1483-1495 pubmed
  324. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  325. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  326. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed 出版商
  327. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  328. Chung B, Guevel B, Reynolds G, Gupta Udatha D, Henriksen E, Stamataki Z, et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45-54 pubmed 出版商
  329. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed 出版商
  330. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed 出版商
  331. Holzlechner M, Strasser K, Zareva E, Steinhäuser L, Birnleitner H, Beer A, et al. In Situ Characterization of Tissue-Resident Immune Cells by MALDI Mass Spectrometry Imaging. J Proteome Res. 2017;16:65-76 pubmed 出版商
  332. Osterburg A, Nelson R, Yaniv B, Foot R, Donica W, Nashu M, et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight. 2016;1:e87270 pubmed 出版商
  333. Isitman G, Tremblay McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy J, et al. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. PLoS ONE. 2016;11:e0164517 pubmed 出版商
  334. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  335. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  336. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  337. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  338. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  339. Milanovic M, Heise N, De Silva N, Anderson M, Silva K, Carette A, et al. Differential requirements for the canonical NF-?B transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol. 2017;95:261-271 pubmed 出版商
  340. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  341. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  342. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  343. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed 出版商
  344. Rudemiller N, Patel M, Zhang J, Jeffs A, Karlovich N, Griffiths R, et al. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. Am J Pathol. 2016;186:2846-2856 pubmed 出版商
  345. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  346. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  347. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  348. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed 出版商
  349. Nerdal P, Peters C, Oberg H, Zlatev H, Lettau M, Quabius E, et al. Butyrophilin 3A/CD277-Dependent Activation of Human ?? T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. J Immunol. 2016;197:3059-3068 pubmed
  350. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed 出版商
  351. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  352. Tang M, Reedquist K, Garcia S, Fernandez B, Codullo V, Vieira Sousa E, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016;55:2248-2259 pubmed
  353. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  354. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  355. Guillou L, Babataheri A, Saitakis M, Bohineust A, Dogniaux S, Hivroz C, et al. T-lymphocyte passive deformation is controlled by unfolding of membrane surface reservoirs. Mol Biol Cell. 2016;27:3574-3582 pubmed
  356. Wang L, Xu D, Qiao Z, Shen L, Dai H, Ji Y. Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncol Lett. 2016;12:2062-2064 pubmed
  357. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed 出版商
  358. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  359. Pageon S, Nicovich P, Mollazade M, Tabarin T, Gaus K. Clus-DoC: a combined cluster detection and colocalization analysis for single-molecule localization microscopy data. Mol Biol Cell. 2016;27:3627-3636 pubmed
  360. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334 pubmed 出版商
  361. Pageon S, Tabarin T, Yamamoto Y, Ma Y, Nicovich P, Bridgeman J, et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proc Natl Acad Sci U S A. 2016;113:E5454-63 pubmed 出版商
  362. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed 出版商
  363. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed 出版商
  364. Guo X, Sun X, Hu D, Wang Y, Fujioka H, Vyas R, et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat Commun. 2016;7:12646 pubmed 出版商
  365. Huynh L, Kusnadi A, Park S, Murata K, Park Min K, Ivashkiv L. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep. 2016;6:31959 pubmed 出版商
  366. Chuang H, Chen Y, Hung W, Li J, Chen D, Lan J, et al. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget. 2016;7:57593-57605 pubmed 出版商
  367. Inoue T, Griffin D, Huq R, Samuel E, Ruano S, Stinnett G, et al. Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016;29:1436-44 pubmed 出版商
  368. Mercer F, Diala F, Chen Y, Molgora B, Ng S, Johnson P. Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis. PLoS Negl Trop Dis. 2016;10:e0004913 pubmed 出版商
  369. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed 出版商
  370. Abdullah C, Li Z, Wang X, Jin Z. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy. Int Immunopharmacol. 2016;39:251-264 pubmed 出版商
  371. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed 出版商
  372. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed 出版商
  373. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed 出版商
  374. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed 出版商
  375. De S, Li D, Song S, Matta B, Barnes B. Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality. Sci Rep. 2016;6:31002 pubmed 出版商
  376. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed 出版商
  377. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed 出版商
  378. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed 出版商
  379. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed 出版商
  380. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed 出版商
  381. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  382. Schweiger T, Berghoff A, Glogner C, Glueck O, Rajky O, Traxler D, et al. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis. 2016;33:727-39 pubmed 出版商
  383. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed 出版商
  384. Fransén Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk A, et al. A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis. PLoS ONE. 2016;11:e0159850 pubmed 出版商
  385. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed 出版商
  386. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  387. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed 出版商
  388. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed 出版商
  389. Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L, et al. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep. 2016;6:29353 pubmed 出版商
  390. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  391. Sommer A, Fadler T, Dorfmeister E, Hoffmann A, Xiang W, Winner B, et al. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model. J Neuroinflammation. 2016;13:174 pubmed 出版商
  392. Konkalmatt P, Asico L, Zhang Y, Yang Y, Drachenberg C, Zheng X, et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight. 2016;1: pubmed
  393. Mo A, Jackson S, Varma K, Carpino A, Giardina C, Devers T, et al. Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development. Mol Cancer Res. 2016;14:795-804 pubmed 出版商
  394. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  395. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed 出版商
  396. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed 出版商
  397. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed 出版商
  398. Liu Y, Xia T, Jin C, Gu D, Yu J, Shi W, et al. FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer. Oncol Lett. 2016;11:3693-3701 pubmed
  399. Seumois G, Zapardiel Gonzalo J, White B, Singh D, Schulten V, Dillon M, et al. Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma. J Immunol. 2016;197:655-64 pubmed 出版商
  400. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed 出版商
  401. Casella G, Garzetti L, Gatta A, Finardi A, Maiorino C, Ruffini F, et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J Neuroinflammation. 2016;13:139 pubmed 出版商
  402. Ma Q, Garber H, Lu S, He H, Tallis E, Ding X, et al. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016;18:985-94 pubmed 出版商
  403. Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, et al. Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors. Oncotarget. 2016;7:39256-39269 pubmed 出版商
  404. Hahn S, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, et al. A key role of GARP in the immune suppressive tumor microenvironment. Oncotarget. 2016;7:42996-43009 pubmed 出版商
  405. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  406. van Ree J, Nam H, Jeganathan K, Kanakkanthara A, van Deursen J. Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol. 2016;18:814-21 pubmed 出版商
  407. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  408. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed 出版商
  409. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  410. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed 出版商
  411. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  412. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed 出版商
  413. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed 出版商
  414. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed 出版商
  415. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed 出版商
  416. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed 出版商
  417. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed 出版商
  418. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  419. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed 出版商
  420. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  421. Bolz M, Ruggli N, Borel N, Pluschke G, Ruf M. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model. PLoS Negl Trop Dis. 2016;10:e0004678 pubmed 出版商
  422. Larabee C, Hu Y, Desai S, Georgescu C, Wren J, Axtell R, et al. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice. Mol Vis. 2016;22:332-41 pubmed
  423. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed 出版商
  424. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed 出版商
  425. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed 出版商
  426. Blas Rus N, Bustos Morán E, Perez de Castro I, de Carcer G, Borroto A, Camafeita E, et al. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nat Commun. 2016;7:11389 pubmed 出版商
  427. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  428. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed 出版商
  429. Kumar A, Abbas W, Colin L, Khan K, Bouchat S, Varin A, et al. Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep. 2016;6:24090 pubmed 出版商
  430. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed 出版商
  431. Del Bel Belluz L, Guidi R, Pateras I, Levi L, Mihaljevic B, Rouf S, et al. The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection. PLoS Pathog. 2016;12:e1005528 pubmed 出版商
  432. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed 出版商
  433. Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed 出版商
  434. Nakatsugawa M, Rahman M, Yamashita Y, Ochi T, Wnuk P, Tanaka S, et al. CD4(+) and CD8(+) TCR? repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep. 2016;6:23821 pubmed 出版商
  435. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed 出版商
  436. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  437. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed 出版商
  438. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed 出版商
  439. O Rourke J, Bogdanik L, Yáñez A, Lall D, Wolf A, Muhammad A, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324-9 pubmed 出版商
  440. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  441. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, et al. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS ONE. 2016;11:e0150411 pubmed 出版商
  442. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  443. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  444. Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, et al. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016;5:e1025194 pubmed
  445. Heylmann D, Kaina B. The γH2AX DNA damage assay from a drop of blood. Sci Rep. 2016;6:22682 pubmed 出版商
  446. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed 出版商
  447. Frodermann V, Van Duijn J, van Puijvelde G, van Santbrink P, Lagraauw H, de Vries M, et al. Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages. J Intern Med. 2016;279:592-605 pubmed 出版商
  448. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed 出版商
  449. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed 出版商
  450. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed 出版商
  451. Singhal G, Fisher F, Chee M, Tan T, El Ouaamari A, Adams A, et al. Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas. PLoS ONE. 2016;11:e0148252 pubmed 出版商
  452. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  453. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed 出版商
  454. Gibson Corley K, Boyden A, Leidinger M, Lambertz A, Ofori Amanfo G, Naumann P, et al. A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis. Peerj. 2016;4:e1600 pubmed 出版商
  455. Garcia Bates T, Kim E, Concha Benavente F, Trivedi S, Mailliard R, Gambotto A, et al. Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1. J Immunol. 2016;196:2870-8 pubmed 出版商
  456. Ha D, Carpenter L, Koutakis P, Swanson S, Zhu Z, Hanna M, et al. Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease. J Transl Med. 2016;14:39 pubmed 出版商
  457. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed 出版商
  458. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed 出版商
  459. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed 出版商
  460. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  461. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed 出版商
  462. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  463. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed 出版商
  464. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed 出版商
  465. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed 出版商
  466. Kindy M, Yu J, Zhu H, Smith M, Gattoni Celli S. A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med. 2016;14:1 pubmed 出版商
  467. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175-82 pubmed 出版商
  468. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  469. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  470. Hesketh A, Maloney C, Behr C, Edelman M, Glick R, Al Abed Y, et al. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation. PLoS ONE. 2015;10:e0145197 pubmed 出版商
  471. Karlsson H, Svensson E, Gigg C, Jarvius M, Olsson Strömberg U, Savoldo B, et al. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. PLoS ONE. 2015;10:e0144787 pubmed 出版商
  472. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed 出版商
  473. Liu T, Weng S, Wang M, Huang W. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216-20 pubmed 出版商
  474. Lee W, Richard J, Lichtfuss M, Smith A, Park J, Courter J, et al. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016;90:2021-30 pubmed 出版商
  475. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed 出版商
  476. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed 出版商
  477. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed 出版商
  478. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed 出版商
  479. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed 出版商
  480. Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong R, Miller K, et al. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development. Cancer Discov. 2016;6:188-201 pubmed 出版商
  481. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed 出版商
  482. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed 出版商
  483. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed 出版商
  484. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed 出版商
  485. Li L, Xu L, Yan J, Zhen Z, Ji Y, Liu C, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129 pubmed 出版商
  486. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed 出版商
  487. Akhmetzyanova I, Drabczyk M, Neff C, Gibbert K, Dietze K, Werner T, et al. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog. 2015;11:e1005224 pubmed 出版商
  488. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  489. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed 出版商
  490. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed 出版商
  491. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed 出版商
  492. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  493. Covarrubias Pinto A, Moll P, Solís Maldonado M, Acuña A, Riveros A, Miró M, et al. Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease. Free Radic Biol Med. 2015;89:1085-96 pubmed 出版商
  494. Martinez N, Agosto L, Qiu J, Mallory M, Gazzara M, Barash Y, et al. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation. Genes Dev. 2015;29:2054-66 pubmed 出版商
  495. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  496. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  497. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631 pubmed 出版商
  498. Cichocki F, Cooley S, Davis Z, DeFor T, Schlums H, Zhang B, et al. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia. 2016;30:456-63 pubmed 出版商
  499. Murayama M, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6:8483 pubmed 出版商
  500. Wawrzyniak M, Ochsner U, Wirz O, Wawrzyniak P, Van De Veen W, Akdis C, et al. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. Allergy. 2016;71:47-57 pubmed 出版商
  501. Silacci M, Lembke W, Woods R, Attinger Toller I, Baenziger Tobler N, Batey S, et al. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. MAbs. 2016;8:141-9 pubmed 出版商
  502. Bego M, Côté Ã, Cohen Ã. Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. J Vis Exp. 2015;: pubmed 出版商
  503. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed 出版商
  504. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed 出版商
  505. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed 出版商
  506. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed 出版商
  507. Ribera Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. 2015;28:1435-47 pubmed 出版商
  508. Wang X, Zeng X, Yang B, Zhao S, Chen W, Guo X. Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model. Mol Med Rep. 2015;12:6775-81 pubmed 出版商
  509. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed 出版商
  510. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  511. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed 出版商
  512. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed 出版商
  513. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed 出版商
  514. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed 出版商
  515. Zhang W, Smythe J, Frith E, Belfield H, Clarke S, Watt S, et al. An innovative method to generate a Good Manufacturing Practice-ready regulatory T-cell product from non-mobilized leukapheresis donors. Cytotherapy. 2015;17:1268-79 pubmed 出版商
  516. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed 出版商
  517. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed 出版商
  518. Klammt C, Novotná L, Li D, Wolf M, Blount A, Zhang K, et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol. 2015;16:961-9 pubmed 出版商
  519. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed 出版商
  520. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed 出版商
  521. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed 出版商
  522. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed 出版商
  523. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed 出版商
  524. Patyka M, Malamud D, Weissman D, Abrams W, Kurago Z. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS ONE. 2015;10:e0132942 pubmed 出版商
  525. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  526. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed 出版商
  527. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed 出版商
  528. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  529. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed 出版商
  530. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed 出版商
  531. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed 出版商
  532. Cimini E, Agrati C, D Offizi G, Vlassi C, Casetti R, Sacchi A, et al. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 2015;10:e0129771 pubmed 出版商
  533. Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen J, et al. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A. 2015;112:8070-5 pubmed 出版商
  534. Fahlbusch F, Ruebner M, Huebner H, Volkert G, Bartunik H, Winterfeld I, et al. Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol. 2015;144:281-91 pubmed 出版商
  535. Shields E, Lam C, Cox A, Rankin M, Van Winkle T, Hess R, et al. Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS ONE. 2015;10:e0129809 pubmed 出版商
  536. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed 出版商
  537. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed 出版商
  538. Soares A, Müller T, Chege G, Williamson A, Burgers W. Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV. Vaccine. 2015;33:3435-9 pubmed 出版商
  539. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  540. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed 出版商
  541. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed 出版商
  542. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed 出版商
  543. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  544. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed 出版商
  545. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed 出版商
  546. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  547. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed 出版商
  548. Liao J, Ovenell K, Curtis E, Cecil D, Koehnlein M, Rastetter L, et al. Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer. J Immunother Cancer. 2015;3:16 pubmed 出版商
  549. Oberg H, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, et al. γδ T cell activation by bispecific antibodies. Cell Immunol. 2015;296:41-9 pubmed 出版商
  550. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed 出版商
  551. Vettermann C, Victor H, Sun Y, Plewa C, Gupta S. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells. J Immunol Methods. 2015;424:14-9 pubmed 出版商
  552. Campia I, Buondonno I, Castella B, Rolando B, Kopecka J, Gazzano E, et al. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells. PLoS ONE. 2015;10:e0126159 pubmed 出版商
  553. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed 出版商
  554. Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570 pubmed
  555. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  556. Bhat N, Kshirsagar M, Bieber M, Teng N. IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies. Immunol Invest. 2015;44:400-10 pubmed 出版商
  557. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed 出版商
  558. Li Y, Kang G, Duan L, Lu W, Katze M, Lewis M, et al. SIV Infection of Lung Macrophages. PLoS ONE. 2015;10:e0125500 pubmed 出版商
  559. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed 出版商
  560. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed 出版商
  561. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed 出版商
  562. Rogers R, Eastham Anderson J, DeVoss J, Lesch J, Yan D, Xu M, et al. Image Analysis-Based Approaches for Scoring Mouse Models of Colitis. Vet Pathol. 2016;53:200-10 pubmed 出版商
  563. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  564. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed 出版商
  565. Maiwald S, Motazacker M, van Capelleveen J, Sivapalaratnam S, van der Wal A, van der Loos C, et al. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. Eur J Hum Genet. 2016;24:86-91 pubmed 出版商
  566. Heinzmann D, Bangert A, Müller A, von Ungern Sternberg S, Emschermann F, Schönberger T, et al. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis. PLoS ONE. 2015;10:e0124606 pubmed 出版商
  567. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed 出版商
  568. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed 出版商
  569. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed 出版商
  570. Katz S, Burga R, McCormack E, Wang L, Mooring W, Point G, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. Clin Cancer Res. 2015;21:3149-59 pubmed 出版商
  571. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed 出版商
  572. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed 出版商
  573. Lougaris V, Ravelli A, Villanacci V, Salemme M, Soresina A, Fuoti M, et al. Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency. Dig Dis Sci. 2015;60:2384-9 pubmed 出版商
  574. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed 出版商
  575. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  576. McClintock S, Warner R, Ali S, Chekuri A, Dame M, Attili D, et al. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models. Cancer Biol Ther. 2015;16:724-32 pubmed 出版商
  577. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed 出版商
  578. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed 出版商
  579. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed 出版商
  580. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed 出版商
  581. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed 出版商
  582. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  583. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed 出版商
  584. Nambiar J, Clarke A, Shim D, Mabon D, Tian C, Windloch K, et al. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs. 2015;7:638-50 pubmed 出版商
  585. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed 出版商
  586. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed 出版商
  587. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed 出版商
  588. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  589. van der Waart A, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunol Immunother. 2015;64:645-54 pubmed 出版商
  590. Rodriguez J, Marchicio J, López M, Ziblat A, Elias F, Fló J, et al. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells. PLoS ONE. 2015;10:e0117484 pubmed 出版商
  591. Boutard B, Vankerckhove S, Markine Goriaynoff N, Sarlet M, Desmecht D, McFadden G, et al. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS ONE. 2015;10:e0118806 pubmed 出版商
  592. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed 出版商
  593. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed 出版商
  594. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed 出版商
  595. Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, et al. Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015;6:6351 pubmed 出版商
  596. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed 出版商
  597. Sakitani E, Nonaka M, Shibata N, Furukawa T, Yoshihara T. Increased expression of thymic stromal lymphopoietin and its receptor in Kimura's disease. ORL J Otorhinolaryngol Relat Spec. 2015;77:44-54 pubmed 出版商
  598. Kwun J, Page E, Hong J, GIBBY A, Yoon J, Farris A, et al. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. Am J Transplant. 2015;15:815-22 pubmed 出版商
  599. Comrie W, Babich A, Burkhardt J. F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J Cell Biol. 2015;208:475-91 pubmed 出版商
  600. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed 出版商
  601. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed 出版商
  602. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed 出版商
  603. Wagner R, Luciani F, Cario André M, Rubod A, Petit V, Benzekri L, et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015;135:1810-1819 pubmed 出版商
  604. Hill E, Ng T, Burton B, Oakley C, Malik K, Wraith D. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015;45:1103-15 pubmed 出版商
  605. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed 出版商
  606. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed 出版商
  607. Zhao H, Bauzon F, Bi E, Yu J, Fu H, Lu Z, et al. Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age. J Biol Chem. 2015;290:5797-809 pubmed 出版商
  608. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed 出版商
  609. Weston C, Shepherd E, Claridge L, Rantakari P, Curbishley S, Tomlinson J, et al. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J Clin Invest. 2015;125:501-20 pubmed 出版商
  610. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed 出版商
  611. Bende R, Slot L, Hoogeboom R, Wormhoudt T, Adeoye A, Guikema J, et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheumatol. 2015;67:1074-83 pubmed 出版商
  612. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed 出版商
  613. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed 出版商
  614. Caramalho I, Nunes Silva V, Pires A, Mota C, Pinto A, Nunes Cabaço H, et al. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus. J Autoimmun. 2015;56:98-110 pubmed 出版商
  615. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed 出版商
  616. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed 出版商
  617. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed 出版商
  618. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  619. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed 出版商
  620. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72:131-9 pubmed 出版商
  621. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  622. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  623. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  624. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed 出版商
  625. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed 出版商
  626. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed 出版商
  627. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  628. Makowski S, Wang Z, Pomerantz J. A protease-independent function for SPPL3 in NFAT activation. Mol Cell Biol. 2015;35:451-67 pubmed 出版商
  629. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  630. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed 出版商
  631. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed 出版商
  632. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed 出版商
  633. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed 出版商
  634. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed 出版商
  635. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed 出版商
  636. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed 出版商
  637. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed 出版商
  638. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed 出版商
  639. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed 出版商
  640. Novinger L, Ashikaga T, Krag D. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer. Cancer Immunol Immunother. 2015;64:29-39 pubmed 出版商
  641. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed 出版商
  642. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed 出版商
  643. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  644. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed 出版商
  645. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  646. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed 出版商
  647. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed 出版商
  648. Landy J, Al Hassi H, Ronde E, English N, Mann E, Bernardo D, et al. Innate immune factors in the development and maintenance of pouchitis. Inflamm Bowel Dis. 2014;20:1942-9 pubmed 出版商
  649. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed 出版商
  650. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  651. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed 出版商
  652. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed 出版商
  653. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed 出版商
  654. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed 出版商
  655. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed 出版商
  656. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  657. Ramirez L, Arango T, Thompson E, Naji M, Tebas P, Boyer J. High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART. J Leukoc Biol. 2014;96:1055-63 pubmed 出版商
  658. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed 出版商
  659. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed 出版商
  660. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed 出版商
  661. Boyd Tressler A, Penuela S, Laird D, Dubyak G. Chemotherapeutic drugs induce ATP release via caspase-gated pannexin-1 channels and a caspase/pannexin-1-independent mechanism. J Biol Chem. 2014;289:27246-63 pubmed 出版商
  662. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed 出版商
  663. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  664. Laurent A, Bindslev N, Johansson B, Berg L. Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of ?? T cells in synovial fluid from patients with arthritis. PLoS ONE. 2014;9:e103683 pubmed 出版商
  665. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed 出版商
  666. de Bock L, Somers K, Fraussen J, Hendriks J, van Horssen J, Rouwette M, et al. Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis. J Immunol. 2014;193:2147-56 pubmed 出版商
  667. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed 出版商
  668. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed 出版商
  669. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed 出版商
  670. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  671. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed 出版商
  672. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  673. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed 出版商
  674. Kawasaki N, Rillahan C, Cheng T, Van Rhijn I, Macauley M, Moody D, et al. Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol. 2014;193:1560-6 pubmed 出版商
  675. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed 出版商
  676. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed 出版商
  677. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed 出版商
  678. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed 出版商
  679. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed 出版商
  680. Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014;85:1386-95 pubmed 出版商
  681. Little J, Bleedorn J, Sutherland B, Sullivan R, Kalscheur V, Ramaker M, et al. Arthroscopic assessment of stifle synovitis in dogs with cranial cruciate ligament rupture. PLoS ONE. 2014;9:e97329 pubmed 出版商
  682. Chan W, Suwannasaen D, Throm R, Li Y, Eldridge P, Houston J, et al. Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia. 2015;29:387-95 pubmed 出版商
  683. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed 出版商
  684. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  685. Adamski M, Li Y, Wagner E, Yu H, Seales Bailey C, Durkin H, et al. Pre-existing hypertension dominates ??T cell reduction in human ischemic stroke. PLoS ONE. 2014;9:e97755 pubmed 出版商
  686. Foster A, Baliwag J, Chen C, Guzman A, Stoll S, Gudjonsson J, et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol. 2014;192:6053-61 pubmed 出版商
  687. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  688. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  689. Jakobsson T, Vedin L, Hassan T, Venteclef N, Greco D, D AMATO M, et al. The oxysterol receptor LXR? protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol. 2014;7:1416-28 pubmed 出版商
  690. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed 出版商
  691. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed 出版商
  692. Schirmer L, Srivastava R, Kalluri S, Böttinger S, Herwerth M, Carassiti D, et al. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. Ann Neurol. 2014;75:810-28 pubmed 出版商
  693. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed 出版商
  694. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed 出版商
  695. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed 出版商
  696. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170:816-23 pubmed 出版商
  697. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner J, Cohen N, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2014;9:e94699 pubmed 出版商
  698. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed 出版商
  699. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed 出版商
  700. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed 出版商
  701. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed 出版商
  702. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed 出版商
  703. Gros A, Robbins P, Yao X, Li Y, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific CD8? tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124:2246-59 pubmed 出版商
  704. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed 出版商
  705. Li Z, Abdullah C, Jin Z. Inhibition of PKC-? preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy. Br J Pharmacol. 2014;171:2913-24 pubmed 出版商
  706. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed 出版商
  707. Witsch T, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, et al. Transglutaminase 2: a new player in bronchopulmonary dysplasia?. Eur Respir J. 2014;44:109-21 pubmed 出版商
  708. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed 出版商
  709. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed 出版商
  710. Rodriguez A, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu A, et al. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus. Cell Immunol. 2014;288:24-30 pubmed 出版商
  711. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  712. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed 出版商
  713. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed 出版商
  714. Lyngaa R, Pedersen N, Schrama D, Thrue C, Ibrani D, Met O, et al. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res. 2014;20:1768-78 pubmed 出版商
  715. Wertheimer A, Bennett M, Park B, Uhrlaub J, Martinez C, Pulko V, et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014;192:2143-55 pubmed 出版商
  716. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  717. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  718. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed 出版商
  719. Sakamoto T, Kobayashi M, Tada K, Shinohara M, Io K, Nagata K, et al. CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1. PLoS ONE. 2014;9:e85762 pubmed 出版商
  720. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed 出版商
  721. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  722. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed 出版商
  723. Wong E, Akilimali N, Govender P, Sullivan Z, Cosgrove C, Pillay M, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE. 2013;8:e83474 pubmed 出版商
  724. Koppensteiner H, H hne K, Gondim M, Gobert F, Widder M, Gundlach S, et al. Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology. 2014;11:1 pubmed 出版商
  725. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed 出版商
  726. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed 出版商
  727. Rodriguez M, Loyd C, Ding X, Karim A, MCDONALD D, Canaday D, et al. Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE. 2013;8:e80938 pubmed 出版商
  728. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed 出版商
  729. Emara M, Turner A, Allalunis Turner J. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol. 2014;44:514-20 pubmed 出版商
  730. Rapetti L, Chavele K, Evans C, Ehrenstein M. B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis. 2015;74:294-302 pubmed 出版商
  731. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed 出版商
  732. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, et al. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion. 2014;54:1305-16 pubmed 出版商
  733. Turcotte S, Gros A, Tran E, Lee C, Wunderlich J, Robbins P, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-43 pubmed 出版商
  734. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  735. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed 出版商
  736. Luan G, Gao Q, Guan Y, Zhai F, Zhou J, Liu C, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol. 2013;72:1000-8 pubmed 出版商
  737. Lin G, Field J, Yu J, Ken R, Neuberg D, Nathan D, et al. NF-?B is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS ONE. 2013;8:e74664 pubmed 出版商
  738. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed 出版商
  739. Saghafian Hedengren S, Sohlberg E, Theorell J, Carvalho Queiroz C, Nagy N, Persson J, et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol. 2013;87:13446-55 pubmed 出版商
  740. Puentes F, van der Star B, Victor M, Kipp M, Beyer C, Peferoen Baert R, et al. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013;10:118 pubmed 出版商
  741. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  742. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  743. Li H, Pauza C. Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology. 2013;10:60 pubmed 出版商
  744. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商
  745. Dintwe O, Day C, Smit E, Nemes E, Gray C, Tameris M, et al. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function. Eur J Immunol. 2013;43:2409-20 pubmed 出版商
  746. Zhou D, Tan R, Lin L, Zhou L, Liu Y. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int. 2013;84:509-20 pubmed 出版商
  747. Fischer M, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136:1799-815 pubmed 出版商
  748. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed 出版商
  749. Kvarnung M, Nilsson D, Lindstrand A, Korenke G, Chiang S, Blennow E, et al. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet. 2013;50:521-8 pubmed 出版商
  750. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed 出版商
  751. Jacobs S, Plessers J, Pinxteren J, Roobrouck V, Verfaillie C, Van Gool S. Mutual interaction between human multipotent adult progenitor cells and NK cells. Cell Transplant. 2014;23:1099-110 pubmed 出版商
  752. Brana C, Frossard M, Pescini Gobert R, Martinier N, Boschert U, Seabrook T. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2014;40:564-78 pubmed 出版商
  753. Paster W, Brockmeyer C, Fu G, Simister P, de Wet B, Martinez Riaño A, et al. GRB2-mediated recruitment of THEMIS to LAT is essential for thymocyte development. J Immunol. 2013;190:3749-56 pubmed 出版商
  754. Introini A, Vanpouille C, Lisco A, Grivel J, Margolis L. Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo. PLoS Pathog. 2013;9:e1003148 pubmed 出版商
  755. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed 出版商
  756. Yan R, Zhong W, Zhu Y, Zhang X. Trichosanthin-stimulated dendritic cells induce a type 2 helper T lymphocyte response through the OX40 ligand. J Investig Allergol Clin Immunol. 2012;22:491-500 pubmed
  757. Field J, Lin G, Okam M, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329-34 pubmed 出版商
  758. Muñoz Ruiz M, Pérez Flores V, Garcillán B, Guardo A, Mazariegos M, Takada H, et al. Human CD3?, but not CD3?, haploinsufficiency differentially impairs ?? versus ?? surface TCR expression. BMC Immunol. 2013;14:3 pubmed 出版商
  759. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed 出版商
  760. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed 出版商
  761. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed 出版商
  762. O CONNOR T, Frei N, Sponarova J, Schwarz P, Heikenwalder M, Aguzzi A. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 2012;8:e1002867 pubmed 出版商
  763. Sharma S, Pichichero M. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281-91 pubmed 出版商
  764. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed 出版商
  765. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed 出版商
  766. Fong B, JIN R, Wang X, Safaee M, Lisiero D, Yang I, et al. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS ONE. 2012;7:e32614 pubmed 出版商
  767. Frahm M, Picking R, Kuruc J, McGee K, Gay C, Eron J, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol. 2012;188:4289-96 pubmed 出版商
  768. Gilroy C, Forzán M, Drew A, Vernau W. Eosinophilia in a cat with acute leukemia. Can Vet J. 2011;52:1004-8 pubmed
  769. Zeng M, Southern P, Reilly C, Beilman G, Chipman J, Schacker T, et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012;8:e1002437 pubmed 出版商
  770. Schneckenleithner C, Bago Horvath Z, Dolznig H, Neugebauer N, Kollmann K, Kolbe T, et al. Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget. 2011;2:1043-54 pubmed
  771. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed 出版商
  772. Meeths M, Chiang S, Wood S, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783-93 pubmed 出版商
  773. Magrini E, Szabo I, Doni A, Cibella J, Viola A. Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12. PLoS ONE. 2011;6:e22482 pubmed 出版商
  774. Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol. 2012;43:209-15 pubmed 出版商
  775. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed 出版商
  776. Gall A, Horowitz A, Joof H, Natividad A, Tetteh K, Riley E, et al. Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Front Microbiol. 2011;2:10 pubmed 出版商
  777. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed 出版商
  778. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed 出版商
  779. Mamedov I, Britanova O, Bolotin D, Chkalina A, Staroverov D, Zvyagin I, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med. 2011;3:201-7 pubmed 出版商
  780. Kuzin I, Sun H, Moshkani S, Feng C, Mantalaris A, Wu J, et al. Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor. Biotechnol Bioeng. 2011;108:1430-40 pubmed 出版商
  781. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, Park J, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol. 2011;186:2106-16 pubmed 出版商
  782. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed 出版商
  783. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed 出版商
  784. Reuwer A, van Eijk M, Houttuijn Bloemendaal F, van der Loos C, Claessen N, Teeling P, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?. J Endocrinol. 2011;208:107-17 pubmed 出版商
  785. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed 出版商
  786. Horowitz A, Behrens R, Okell L, Fooks A, Riley E. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol. 2010;185:2808-18 pubmed 出版商
  787. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed 出版商
  788. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed 出版商
  789. Zhou J, Belov L, Huang P, Shin J, Solomon M, Chapuis P, et al. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. J Immunol Methods. 2010;355:40-51 pubmed 出版商
  790. Hunter P, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum. 2010;62:896-907 pubmed 出版商
  791. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed 出版商
  792. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19:317-22 pubmed 出版商
  793. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed 出版商
  794. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed 出版商
  795. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed 出版商
  796. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed 出版商
  797. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed 出版商
  798. Richardson M, Carroll R, Stremlau M, Korokhov N, Humeau L, Silvestri G, et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol. 2008;82:11117-28 pubmed 出版商
  799. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed 出版商
  800. Lunemann J, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181:991-1000 pubmed
  801. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed 出版商
  802. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed 出版商
  803. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  804. Muniz J, McCauley L, Scherer J, Lasarev M, Koshy M, Kow Y, et al. Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study. Toxicol Appl Pharmacol. 2008;227:97-107 pubmed
  805. Sangiolo D, Lesnikova M, Nash R, Jensen M, Nikitine A, Kiem H, et al. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Gene Ther. 2007;14:1549-54 pubmed
  806. Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-7 pubmed
  807. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  808. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  809. Estefanía E, Flores R, Gómez Lozano N, Aguilar H, Lopez Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol. 2007;178:4402-10 pubmed
  810. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  811. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  812. Clarke S, Betts G, Plant A, Wright K, El Shanawany T, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129 pubmed
  813. Xin K, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, et al. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol. 2006;80:11899-910 pubmed
  814. Hoves S, Krause S, Schutz C, Halbritter D, Scholmerich J, Herfarth H, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol. 2006;177:2691-8 pubmed
  815. Quiroga M, Pasquinelli V, Martinez G, Jurado J, Zorrilla L, Musella R, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74 pubmed
  816. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  817. Barsov E, Andersen H, Coalter V, Carrington M, Lifson J, Ott D. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett. 2006;105:26-37 pubmed
  818. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  819. Schaap A, Fortin J, Sommer M, Zerboni L, Stamatis S, Ku C, et al. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J Virol. 2005;79:12921-33 pubmed
  820. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  821. Tas S, Quartier P, Botto M, Fossati Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis. 2006;65:216-21 pubmed
  822. Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoe K, et al. Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod. 2005;11:451-7 pubmed
  823. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  824. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  825. Stütz A, Graf P, Beinhauer B, Hammerschmid F, Neumann C, Woisetschläger M, et al. CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL-4. Eur J Immunol. 2005;35:575-83 pubmed
  826. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  827. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173:6000-8 pubmed
  828. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  829. Bonanno G, Perillo A, Rutella S, De Ritis D, Mariotti A, Marone M, et al. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion. 2004;44:1087-97 pubmed
  830. Asin S, Fanger M, Wildt Perinic D, Ware P, Wira C, Howell A. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004;190:236-45 pubmed
  831. Yamada H, Shimada S, Kato E, Morikawa M, Iwabuchi K, Kishi R, et al. Decrease in a specific killer cell immunoglobulin-like receptor on peripheral natural killer cells in women with recurrent spontaneous abortion of unexplained etiology. Am J Reprod Immunol. 2004;51:241-7 pubmed
  832. Beinhauer B, McBride J, Graf P, Pursch E, Bongers M, Rogy M, et al. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol. 2004;34:74-80 pubmed
  833. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  834. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  835. Tjernlund A, Fleener Z, Behbahani H, Connick E, Sonnerborg A, Broström C, et al. Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells. AIDS. 2003;17:1303-10 pubmed
  836. Rahimi K, Maerz H, Zotz R, Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry B Clin Cytom. 2003;53:63-9 pubmed
  837. Rouard H, Leon A, De Reys S, Taylor L, Logan J, Marquet J, et al. A closed and single-use system for monocyte enrichment: potential for dendritic cell generation for clinical applications. Transfusion. 2003;43:481-7 pubmed
  838. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261-8 pubmed
  839. Dekel B, Burakova T, Arditti F, Reich Zeliger S, Milstein O, Aviel Ronen S, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med. 2003;9:53-60 pubmed
  840. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  841. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  842. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  843. Thompson S, Luyrink L, Graham T, Tsoras M, Ryan M, Passo M, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001;166:6899-906 pubmed
  844. Telford W, Moss M, Morseman J, Allnutt F. Cryptomonad algal phycobiliproteins as fluorochromes for extracellular and intracellular antigen detection by flow cytometry. Cytometry. 2001;44:16-23 pubmed
  845. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  846. Miller A, Kraiem Z, Sobel E, Lider O, Lahat N. Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix. Thyroid. 2000;10:945-50 pubmed
  847. Lafont B, Gloeckler L, D Hautcourt J, Gut J, Aubertin A. One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry. Cytometry. 2000;41:193-202 pubmed
  848. Kappelmayer J, Gratama J, Karászi E, Menendez P, Ciudad J, Rivas R, et al. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods. 2000;242:53-65 pubmed
  849. Graziani Bowering G, Filion L. Down regulation of CD4 expression following isolation and culture of human monocytes. Clin Diagn Lab Immunol. 2000;7:182-91 pubmed
  850. Martín Henao G, Picon M, Amill B, Querol S, Gonzalez J, Martinez C, et al. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion. 2000;40:35-43 pubmed
  851. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  852. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  853. Paz Miguel J, Flores R, Sanchez Velasco P, Ocejo Vinyals G, Escribano de Diego J, López de Rego J, et al. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J Immunol. 1999;163:5399-410 pubmed
  854. Cron R, Bort S, Wang Y, Brunvand M, Lewis D. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. J Immunol. 1999;162:860-70 pubmed
  855. Kim C, Pelus L, White J, Applebaum E, Johanson K, Broxmeyer H. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-24 pubmed
  856. Verhasselt B, De Smedt M, Verhelst R, Naessens E, Plum J. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood. 1998;91:431-40 pubmed
  857. Basch R, Quito F, Beh J, Hirst J. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. Stem Cells. 1997;15:314-23 pubmed
  858. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed
  859. Borst J, Alexander S, Elder J, Terhorst C. The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem. 1983;258:5135-41 pubmed
  860. Furley A, Mizutani S, Weilbaecher K, Dhaliwal H, Ford A, Chan L, et al. Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex. Cell. 1986;46:75-87 pubmed
  861. Gold D, Puck J, Pettey C, Cho M, Coligan J, Woody J, et al. Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature. 1986;321:431-4 pubmed